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The United States Department of Energy (U.S. DOE) has recently implemented a series 
of strategic initiatives to address long-term radiological surveillance needs at former U.S. 
nuclear test sites in the Marshall Islands. The plan is to engage local atoll communities 
in developing shared responsibilities for implementing radiation protection monitoring 
programs for resettled and resettling populations in the northern Marshall Islands. Using 
the pooled resources of the U.S. DOE and local atoll governments, individual 
radiological surveillance programs have been developed in whole body counting and 
plutonium urinalysis in order to accurately assess radiation doses resulting from the 
ingestion and uptake of fallout radionuclides contained in locally grown foods. 
Permanent whole body counting facilities have been established at three separate 
locations in the Marshall Islands including Enewetak Island (Figure 1) (Bell et al., 2002). 
These facilities are operated and maintained by Marshallese technicians with scientists 
from the Lawrence Livermore National Laboratory (LLNL) providing on-going technical 
support services. Bioassay samples are collected under controlled conditions and 
analyzed for plutonium isotopes at the Center for Accelerator Mass Spectrometry at 
LLNL using state-of-the art measurement technologies. We also conduct an on-going 
environmental monitoring and characterization program at selected sites in the northern 
Marshall Islands. The aim of the environmental program is to determine the level and 
distribution of important fallout radionuclides in soil, water and local foods with a view 
towards providing more accurate and updated dose assessments, incorporating 
knowledge of the unique behaviors and exposure pathways of fallout radionuclides in 
coral atoll ecosystems. These scientific studies have also been essential in helping 
guide the development of remedial options used in support of island resettlement. 
Together, the individual and environmental radiological surveillance programs are 
helping meet the informational needs of the U.S. DOE and the Republic of the Marshall 
Islands. Our updated environmental assessments provide a strong scientific basis for 
predicting future change in exposure conditions especially in relation to changes in life-
style, diet and/or land-use patterns. This information has important implications in 
addressing questions about existing (and future) radiological conditions on the islands, in 
determining the cost and estimating the effectiveness of potential remedial measures, 
and in general policy support considerations. Perhaps most importantly, the recently 




Figure 1. The Enewetak Radiological Laboratory located on Enewetak 
Island, Enewetak Atoll. 
communities with an unprecedented level of radiation protection monitoring where, for 
the first time, local resources are being made available to monitor resettled and 
resettling populations on a continuous basis. 
As a hard copy supplement to Marshall Islands Program website (http://eed.llnl.gov/mi/), 
this document provides an overview of the individual radiation protection monitoring 
program established for the Enewetak Atoll population group along with a full disclosure 
of all verified measurement data (2002-2004). Readers are advised that an additional 
feature of the associated web site is a provision where users are able calculate and track 
doses delivered to volunteers (de-identified information only) participating in the Marshall 
Islands Radiological Surveillance Program.  
 
BRIEF HISTORY OF NUCLEAR TESTING IN THE MARSHALL ISLANDS 
Immediately after WWII, the United States created a Joint Task Force to develop a 
nuclear weapons testing program. Planners examined a number of possible locations in 
the Atlantic Ocean, the Caribbean, and the Central Pacific but decided that coral atolls in 
the northern Marshall Islands offered the best advantages of stable weather conditions, 
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fewest inhabitants to relocate and isolation with hundreds of miles of open-ocean to the 
west where trade winds were likely to disperse radioactive fallout. During the period 
between 1945 and 1958, a total of 67 nuclear tests were conducted on Bikini and 
Enewetak Atolls and adjacent regions within the Republic of the Marshall Islands. The 
most significant contaminating event was the Castle Bravo test conducted on March 1, 
1954 (Figure 2). Bravo was an experimental thermonuclear device with an estimated 
explosive yield of 15 MT (USDOE, 2000), and led to widespread fallout contamination 
over inhabited islands of Rongelap and Utrōk Atolls, as well as other atolls to the east of 
Bikini. Today, the United States Department of Energy (U.S. DOE) through the Office of 
Health Studies continues to provide environmental monitoring, healthcare and medical 
services on the affected atolls. 
Key directives of the Marshall Islands Dose Assessment and Radioecology Program 
conducted at the Lawrence Livermore National Laboratory are (1) to provide technical 
support services, data and oversight in establishing radiological surveillance monitoring 
programs for resettled and resettling populations in the northern Marshall Islands; (2) to 
develop comprehensive assessments of current (and potential changing) radiological 
conditions on the islands; and (3) provide recommendations for remediation of 
contaminated sites and verify the effects of any actions taken.  
 
Figure 2. Map of the Republic of Marshall Islands showing the fallout 
pattern from the Bravo thermonuclear test conducted on March 1 of 1954. 
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ENEWETAK ATOLL 
People & Events on Enewetak Atoll | Post Testing Era and Initial Cleanup 
Activities  
 
People and Events on Enewetak Atoll 
After an initial series of nuclear tests on Bikini Atoll in 1946, local inhabitants of 
Enewetak Atoll were relocated to a new home on Ujelang Atoll in December 1947 in 
preparation for scheduling of the first series of nuclear tests on Enewetak. Operation 
Sandstone commenced in April 1948 and included 3 tests on top of 60 m high steel 
towers located separately on the islands of Enjebi, Aomen, and Runit. An additional 4 
near surface tests were conducted on towers as part of Operation Greenhouse during 
1951. Operation Ivy, in 1952, set the stage for the first test of a large thermonuclear 
device. The Mike thermonuclear blast of 31 October 1952 had an explosive yield of 10.4 
Mt (USDOE, 2000) vaporizing the island of Elugelab and leaving behind a deep crater 
about 1 km in diameter. Early analysis of Mike fallout debris showed the presence of two 
new isotopes of plutonium, plutonium-244 (244Pu) and plutonium-246 (246Pu), and lead to 
the discovery of the new heavy elements, Einsteinium and Fermium. Operation Castle 
involved a single test on Enewetak in 1954 and 5 high-yield tests on Bikini. A total of 11 
nuclear tests were also conducted on Enewetak in 1956 as part of Operation Redwing 
including an air burst from a balloon located over water. 
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In 1958, the United States anticipated the acceptance of a call for suspension of 
atmospheric nuclear testing and assembled a large number of devices for testing before 
the moratorium came into effect. From April through August 1958, 22 near-surface 
nuclear denotations were conducted on Enewetak Atoll either on platforms, barges or 
underwater, 10 tests at Bikini Atoll, 2 tests near Johnson Atoll, and a high altitude test 
about 100 kms west of Bikini Atoll. Most nuclear tests conducted on Enewetak Atoll were 
detonated in the northern reaches of the atoll and produced highly localized fallout 
contamination of neighboring islands and the atoll lagoon. As a consequence, the 
northern islands on Enewetak received significantly higher levels of fallout deposition 
containing a range of fission products, activation products and unfissioned nuclear fuel. 
By the time the test moratorium came into effect on 31 October 1958, the United States 
had conducted 42 tests on Enewetak Atoll. 
Post Testing Era and Initial Cleanup Activities 
Enewetak Atoll continued to be used for defense programs until the start of a cleanup 
and rehabilitation program in 1977. There were five feasible approaches considered by 
the Defense Nuclear Agency (DNA, 1981) for cleanup of Enewetak Atoll. The final plan 
called for 1) removing all radioactive and non-radioactive debris (equipment, concrete, 
scrap metal, etc.), 2) removing all soil that exceeded 14.8 Bq (400 pCi) of plutonium per 
gram of soil 3) removing or amending soil between 1.48 and 14.8 Bq (40 and 400 pCi) of 
plutonium per gram of soil, determined on a case-by-case basis depending on ultimate 
land use, and 4) disposing and stabilizing all this accumulated radioactive waste into a 
crater on Runit Island and capping it with a concrete dome. Over 4,000 U.S. servicemen 
assisted in the cleanup operations, with 6 lives lost in accidents, in what became known 
as the Enewetak Radiological Support Project (DOE, 1982). Over 73,000 cubic meters 
of soil from the surface of 6 islands was removed and deposited in Cactus crater on 
Runit Island. The Nevada Operations Office of the Department of Energy was 
responsible for certification of radiological conditions of each island upon completion of 
the project. The Operations Office also developed several large databases to document 
radiological conditions before and after the cleanup operations, and to provide data to 
update available dose assessments. The Enewetak cleanup was largely focused on the 
removal and containment of plutonium along with other heavy radioactive elements. 
However, even during this early period of cleanup and rehabilitation, the adequacy of 
cleanup of the northern islands on Enewetak was brought into question because 
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predictive dose assessments showed that ingestion of cesium-137 and other fission 
products from consumption of locally grown terrestrial foods was the most significant 
route for human exposure to residual fallout contamination on coral atolls affected by the 
nuclear test program. 
The people of Enewetak remained on Ujelang Atoll until resettlement of Enewetak Island 
in 1980. Between 1980 and 1997, the resettled population living on Enewetak Island was 
periodically monitored for internally deposited radionuclides by scientists from the 
Brookhaven National Laboratory using whole body counting and plutonium urinalysis 
(Sun et al., 1997a; 1997b). More recently, the Department of Energy agreed to design 
and construct a radiological laboratory on Enewetak Island, and help develop the 
necessary local resources and technical expertise to maintain and operate the facility. 
This cooperative effort was formalized in a Memorandum of Understanding signed by 
the U.S. Department of Energy, the Republic of the Marshall Islands, and the 
Enewetak/Ujelang Local Atoll Government in August of 2000 (MOU, 2000). Construction 
on the Enewetak Radiological Laboratory was completed in May of 2001. The laboratory 
facility incorporates both a permanent whole body counting system−to assess radiation 
doses from internally deposited cesium-137−and clean living space for collecting in vitro 
bioassay samples. Scientists from the Lawrence Livermore National Laboratory continue 
to support the operation of the facility and are responsible for systems maintenance, 
training and data quality assurance. 
WHOLE BODY COUNTING 
What is Whole Body Counting? | What Will the Whole Body Counting Show? | 
Estimating Doses from Cesium-137 Based on Whole Body Counting | Dose to 
Enewetak Island Residents from Internally Deposited Cesium-137 
What is Whole Body Counting?  
The whole body counting systems installed in the Marshall Islands contain large volume 
sodium iodide radiation detectors that measure gamma rays coming from radionuclides 
deposited in the body. The detector systems are modeled after the ‘Masse-Bolton Chair’ 
design (Figure 3) and can be used to detect high-energy gamma-emitting radionuclides 
from the decay of cesium-137, cobalt-60 and potassium-40 in most of the body and all of 
the internal organs. Using established protocols the whole body counting measurement 
data are converted into an annual effective dose using specially designed computer 
software (Canberra, 1998a; 1998b). 
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There are currently three operational whole body counting facilities in the Republic of the 
Marshall Islands. These facilities are located on Enewetak, Rongelap and Majuro Atolls. 
The whole body counting systems are calibrated using a mixed-gamma point source. 
The point source calibration procedure was developed by cross-reference to a Bottle 
Man-akin Absorption (BOMAB) phantom (or human surrogate) calibration source 
containing a standard mix of gamma-emitting radionuclides traceable to the U.S. 
National Institute of Standards and Technology (NIST). 
Wherever possible, the whole body counting program in the Marshall Islands is 
conducted using the same quality requirements as established under the U.S. 
Department of Energy Laboratory Accreditation Program (DOELAP) for internal 
dosimetry. Background and other quality control check counts are performed on a daily 
basis to ensure that the measurement system conforms to all applicable quality 
requirements. Also, each whole body counting facility participates in external 
performance testing exercises with the Hazards Control Department at the Lawrence 
Livermore National Laboratory using ‘5 bottle phantoms’ prepared under contract by the 
Oak Ridge National Laboratory. These performance test samples are distributed around 
each of the facilities including a mirror whole body counting system located at Livermore. 
The performance of the facilities is then evaluated by comparing results with those 
obtained by the Hazards Control Department at the Lawrence Livermore National 
Laboratory−a DOELAP accredited facility−and with the reference values supplied by the 
Oak Ridge National Laboratory. Under this quality assurance program, the data returned 
by these remote facilities in the Marshall Islands has consistently exceeded ANSI 13.30 
criteria for measurement accuracy and precision.  
Local Marshallese technicians are responsible for all daily operations within the facilities 
including scheduling of personal counts, performing systems performance checks, data 
reduction, and reporting to program volunteers. The technicians receive an initial six 
weeks of intensive training at the Lawrence Livermore National Laboratory and are 
employed to run the facilities for up to 40 hours per week. Scientists from the Lawrence 
Livermore National Laboratory provide on-going technical support services, advanced 
training in whole body counting and basic health physics, and perform a more detailed 




Figure 3. The Enewetak Radiological Laboratory whole body 
counter with a plastic calibration phantom seated in the chair. 
What Will the Whole Body Counting Show? 
The main pathway for exposure to residual fallout contamination in the northern Marshall 
Islands is through ingestion of cesium-137 contained in locally grown foods such as 
coconut, Pandanus fruit and breadfruit. The strategic objective of the Marshall Islands 
Whole Body Counting Program is to offer island residents an unprecedented level of 
radiation protection monitoring until such time that it is clearly demonstrated that 
radiation surveillance measures can be relaxed. The value of this type of radiation 
protection monitoring program lies in the fact that whole body count data provides a 
direct measure of the full range of radionuclide uptakes into the local population. 
Information about potential high-end health risks and seasonal fluctuations in the body 
burden of cesium-137 within exposed Marshallese can be assessed from measurement 
data rather than relying on a range of assumptions from different dietary scenarios. 
In combination with environmental monitoring data, residents who receive a whole body 
count showing the presence of cesium-137 can now make an informed decision about 
their eating habits or life-style based on what is considered a “safe” or acceptable health 
risk. The Republic of the Marshall Islands Nuclear Claims Tribunal has adopted a 
standard for cleanup of radioactively contaminated sites of 0.15 millisievert (mSv) per 
year (or 15 mrem per year) [EDE, Effective Dose Equivalent] using a lifetime cancer risk 
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criterion recommended by the U.S. Environmental Protection Agency (EPA). As 
displaced communities return to their ancestral homelands, the Marshall Islands Whole 
Body Counting Program will allow the U.S. Department of Energy to monitor the return of 
the people and help ensure that the radiation related health risks remain at or below 
these established standards. 
Estimating Doses from Cesium-137 Based Whole Body Counting 
People living in the Marshall Islands may be exposed to cesium-137 contained in their 
diets from eating locally grown food crop products such as coconut. Whole body 
counting provides a direct measure of the amount of cesium-137 inside the body of 
people. The biokinectic behavior of cesium-137 inside the human body is well known 
and allows information from the whole body counter to be converted to a radiation dose. 
The radiation dose is what is used to quantify the potential human health risk associated 
with radiation exposure. The dosimetric data displayed in graphics presented in this 
report and the associated web site are based on the calendar year committed effective 
dose equivalent (CEDE) from intakes of radionuclides in the year of measurement 
projected over 70 years [details on methodologies can be found in Appendix 3, 
Technical Basis Document, see under Daniels et al., (2006)]. Dose equivalent is given in 
units of rem, the conventional units used by federal and state agencies in the United 
States. The SI unit of dose equivalent is the joule per kilogram or sievert (Sv). Doses 
from exposure to environmental radioactivity (natural or manmade) are normally 
expressed as 1/1000th of the base unit, i.e., in millirem (mrem) or millisievert (mSv). 1 
mSv is equal to 100 mrem.  
INFORMATION NOTE 
We have recently updated our methodologies for computing doses from the whole body 
counting and plutonium urinalysis programs (refer to the Technical Basis Document, 
Daniels et al., 2006). This new methodology uses a 50 y dose commitment and complies 
more fully with ICRP methodology. The algorithms developed to allow users to compute 
doses directly from the measurement data made available on the web site (post 2004) 





Doses to Enewetak Island Residents from Internally Deposited Cesium-137 
The individual (de-identified) measurement data developed under the whole body 
counting program on Enewetak Island are tabulated in Appendix I, TABLE 1.  
The frequency distribution of the committed effective dose equivalent received by 
Enewetak Island residents from exposure to dietary cesium-137 annualized to the year 
of measurement is shown in Figure 4. 
The majority of people living on Enewetak Island received internal doses from intakes of 
cesium-137 of less than 1 mrem per year. The population average committed effective 
dose equivalent for each measurement year was 0.5±0.5 mrem in 2001 (N = 417), 
0.8±0.8 mrem in 2002 (N=131), 0.5±0.7 mrem in 2003 (N = 197) and 0.7±1.3 mrem in 
2004 (N = 316). The corresponding maximal individual committed effective dose 
equivalent for each measurement year was 3.2 mrem, 4.9 mrem, 4.0 mrem and 11.5 
mrem, respectively 
 
Figure 4. Frequency distribution of the committed effective dose 
equivalent for the Enewetak population group from internally 
deposited cesium-137 annualized to the measurement year (2001 to 
2004). Summary graphics for each measurement year are based on 
committed dose received over 70 years; refer supporting 
documentation (Daniels et al., 2006, Appendix 3).  
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The average annualized committed effective dose equivalent to adults (N = 767), 
teenagers (N = 235), pre-teenagers (N = 109) and children (47 individuals) over the 
history of the surveillance program (2001-2004) was 0.64±0.71 mrem per year, 0.5±1.2 
mrem per year, 0.56±1.2 mrem per year and 0.45±1.7 mrem per year, respectively. The 
average population dose for adult males of 0.74±0.75 mrem per year (N = 508) was 
slightly higher than that observed in adult females of around 0.43±0.56 mrem per year 
(N = 259). It should be noted that the body burden of cesium-137 in about 1 of every 3 
volunteers on Enewetak Island fall below the critical level of measurement (Lc~0.05 
kBq).  
The committed effective dose equivalent delivered to Enewetak Atoll residents from 
ingestion of cesium-137 can be compared with natural background doses of 140 mrem 
per year in the Marshall Islands and 300 mrem per year in the United States. Enewetak 
Atoll residents are also receiving doses from ingestion of cesium-137 that are 
significantly below the annual dose criteria of 100 mrem per year, excluding medical 
irradiation, imposed in 10CFR Part 20 (NRC, 1994) for protection of the public. 
Consequently, these results appear to demonstrate that Enewetak residents are not 
being exposed to significantly elevated levels of cesium-137 in their diets. In terms of 
assessing doses to maximally exposed individuals, people who consume foods from the 
northern islands are more likely to acquire a higher whole body burden of cesium-137. 
The continuing whole body counting program on Enewetak Island should take steps to 
ensure that people who occasionally ‘binge’ on foods from the northern islands are 
carefully monitored. Under these circumstances, the annual dose delivered to an 
individual may be dominated by intakes of cesium-137 from occasional visits to the 
northern islands where local terrestrial foods typically contain higher average 
concentrations of cesium-137 (as well as other fallout radionuclides). 
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PLUTONIUM URINALYSIS (BIOASSAY) MONITORING 
What is Plutonium Urinalysis | Routes of Exposure | Purpose of Plutonium 
Urinalysis Monitoring | Methods of Detection | Method Validation | Plutonium 
Urinalysis Monitoring on Enewetak | Plans for the Future 
What is Plutonium Urinalysis Monitoring? 
Plutonium urinalysis is a very sensitive in-vitro bioassay measurement technique used to 
determine the amount of plutonium in human urine as a means of estimating the 
systemic burden (or total amount of plutonium) in the human body. Plutonium urinalysis 
 
 
Schematic diagram of the systems configuration for measuring plutonium 
isotopes using Accelerator Mass Spectrometry (AMS). AMS is about 200 to 
400 times more sensitive than standard techniques commonly employed in 
routine internal dosimetry programs,  and far exceeds the standard 
requirements established under the latest United States Department of 
Energy regulation 10CFR 835 for in vitro bioassay monitoring of alpha-
emitting radionuclides such as plutonium-239. 
tests are performed by collecting urine from individuals over a 24-hour period. The test 
turns a urine sample into a powder which scientists analyze by counting the number of 
plutonium atoms contained in the sample. Under the Marshall Islands Radiological 
Surveillance Program, we have developed a new state-of-the-art technology for 
measuring the amount of plutonium in urine based on Accelerator Mass Spectrometry. 
Everybody has a small amount of plutonium in their bodies. Plutonium occurs in nature 
at very low concentrations but human exposure to plutonium increased dramatically 
through the 1950s as a result of global fallout from atmospheric nuclear weapons 
testing. Marshall Islanders are potentially exposed to higher levels of contamination in 
the environment as a result of close-in and regional fallout deposition. 
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Routes of Exposure 
Plutonium is an important radioactive element produced in nuclear explosions. 
Plutonium emits alpha particles (or alpha-rays). Alpha-particles have a short range in 
tissue (about ~40 μm) and cannot be measured by detectors external to the body. 
However, as heavy slow moving charged particles they have a high relative 
effectiveness to disrupt or cause harm to the content of biological cells. As a 
consequence, in-vitro bioassay tests have been developed to test for the presence of 
systemic plutonium in the human body based on measured urinary excretion patterns 
and modeled metabolic behaviors of the absorbed isotopes. 
The main pathway for exposure to plutonium in humans is inhalation of contaminated 
dust particles in the air that people breathe. Inhaled or ingested plutonium may 
eventually end up in various organs–especially the lung, liver and bone–resulting in 
continuous exposure of these tissues to alpha particle radiation. Plutonium remains in 
the body for a long time but the systemic uptake of plutonium for people living in the 
northern Marshall Islands is still expected to be very low (Robison et al., 1980; 1982; 
1997). 
Inhalation exposure can be estimated from the product of the soil concentration, 
resuspension enhancement factors and inhalation dose conversion factors for 
radionuclides of interest. These estimates show that the projected dose contribution from 
exposure to plutonium in the Marshall Islands is less that 5% of the total lifetime dose 
from exposure to residual fallout contamination in the environment (Robison et al., 1980; 
1982; 1997). However, plutonium is a major concern to people living in the northern 
Marshall Islands because of its long half-life and persistence in the environment. 
Radioactive debris deposited in lagoon sediments of coral atolls formed a reservoir and 
source term for remobilization and transfer of plutonium through the marine food chain 
and potentially to man. Also, elevated levels of plutonium in the terrestrial environment 
from close-in fallout deposition represent potential long-term inhalation and/or ingestion 
hazards. Early characterization of the terrestrial environment also revealed the presence 
of hotspots containing milligram-sized pieces of plutonium metal that clearly required 
some form of remediation (DOE, 1982). Consequently, dose assessments and atoll 
rehabilitation programs in the Marshall Islands have historically given special 
consideration to monitoring plutonium uptake in resettled and resettling populations. 
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What is the Purpose of Plutonium Urinalysis Monitoring in the Marshall Islands? 
Plutonium urinalysis is a measurement technique that ultimately provides information to 
individuals on the amount of plutonium they have in their bodies. Although plutonium is 
expected to be a minor contributor to the total manmade dose, it is a concern to people 
living in the northern Marshall Islands who are potentially exposed to elevated levels of 
plutonium in the environment from close-in or regional fallout deposition. Consequently, 
the United States Department of Energy has agreed to monitor resettlement workers and 
perform a limited number of urinalysis tests on island residents using advanced 
measurement technologies available at the Lawrence Livermore National Laboratory. 
The measurement technique currently employed at the Lawrence Livermore National 
Laboratory is based on Accelerator Mass Spectrometry. AMS is about 200 to 400 times 
more sensitive than monitoring techniques commonly employed in internal dosimetry 
monitoring programs in the United States, and far exceeds the standard requirements 
established under the latest Department of Energy regulation 10CFR 835 for in vitro 
bioassay monitoring of alpha-emitting radionuclides such as plutonium-239. 
The Marshall Islands Plutonium Urinalysis Monitoring Program was implemented under 
the following action plan:- 
1) To provide more reliable and accurate data to assess baseline and potentially 
significant incremental uptakes of plutonium within resettled and/or resettling 
populations in the Marshall Islands. 
2) To monitor plutonium exposure in critical populations groups such as field 
workers engaged in soil remediation or agriculture.  
3) To determine occupational and/or public exposures to plutonium in the 
Marshall Islands and confirm they are below levels that will impact human 
health.  
4) To participate in analytical proficiency testing programs to ensure that the 
accuracy and reliability of our measurement data meets all applicable quality 
requirements and that procedures are carefully documented.  
5) To document and test the reliability of using environmental data to assess 
human exposure (and uptake) to plutonium in a coral atoll ecosystem. 
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Methods of Detection of Plutonium in Urine 
Researchers from the Brookhaven National Laboratory (BNL) were the first to use whole 
body counting and plutonium urinalysis techniques to assess intakes of internally 
deposited radionuclides in Marshallese populations (Sun et al., 1992; 1995; 1997a; 
1997b; 1997c; Conard 1982; Lessard et al., 1984; Miltenberger et al., 1981; Greenhouse 
et al., 1980). Classical methods for evaluating intakes of plutonium in bioassay samples 
include alpha-spectrometry and fission-track analysis. Alpha spectrometry cannot 
distinguish between plutonium-239 and plutonium-240, and results are normally reported 
for the sum of the two isotopes. Moreover, alpha spectrometry lacks the necessary 
detection sensitivity to accurately assess systemic plutonium uptake and dose in the 
Marshall Islands (Hamilton et al., 2004). Fission Track Analysis is limited to the 
quantification of plutonium-239 but with a reported detection limit (MDA, Minimum 
Detection Amount) of around 1 to 3 microBecquerel (μBq) of plutonium-239, offers 
greatly improved potential for assessing likely uptakes associated with low-level chronic 
exposure to plutonium in the environment.  
Under the Marshall Islands Plutonium Urinalysis Program, urine samples were initially 
sent to the University of Utah for analysis of plutonium using fission track analysis. 
Fission is a process where heavy nuclei such as plutonium and uranium break up into 
two large fragments. Fission may occur spontaneously or be induced by collisions with 
neutrons. During fission track analysis samples are exposed to a source of neutrons in a 
reactor in contact with a quartz or plastic slide. Any resulting fission fragments leave 
behind tracks on the slide that can be counted under an optical microscope to determine 
the amount of plutonium present. Historically, fission track analysis has been plagued 
with a number of deficiencies including the use of less than reliable and tedious 
preparative methods, low chemical yields, contamination issues and inaccurate 
quantification. The University of Utah and the Brookhaven National Laboratory improved 
on the fission track process methodology, and adopted a more rigorous approach to 
data reduction and quality assurance in support of urinalysis testing programs in the 
Marshall Islands.  
More recently, scientists from the Lawrence Livermore National Laboratory have 
developed a low-level detection technique for determination of plutonium isotopes in 
bioassay samples based Accelerator Mass Spectrometry (Brown et al., 2004; Hamilton 
et al., 2006). The technique has vastly improved the quality and reliability of 
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assessments of urinary excretion of plutonium from Marshall Islanders and avoids many 
of the disadvantages of using conventional atom counting techniques or other competing 
new technologies.  
INFORMATION NOTE 
There are two main isotopes of plutonium in the environment–namely plutonium-239 
(239Pu) and plutonium-240 (240Pu). The isotopic composition of plutonium (i.e., the 
relative amounts of 239Pu and 240Pu) may vary significantly depending on the source of 
plutonium. For example, the 240Pu/239Pu content of nuclear fallout from high−yield 
atmospheric nuclear tests in the Marshall Islands produced 240Pu/239Pu atom ratio 
signatures of ~0.35 compared with that present in integrated global fallout deposition 
(~0.18) or unfissioned nuclear fuel (~0.05). Consequently, it may be possible to use 
urinalysis testing and plutonium isotope measurements as an investigative tool to assess 
source specific exposures to Bravo as well as other nuclear test events.  
Method Validation 
Method validation is the process used to monitor and document the quality of the 
measurement data. Methods validation testing under the Marshall Islands Plutonium 
Urinalysis Program has included the labs participation in an interlaboratory exercise 
organized by the U.S. National Institute of Standards and Technology (NIST). The 
results of this exercise clearly demonstrate that Accelerator Mass Spectrometry is well 
suited for detection of μBq concentrations of plutonium-239 and plutonium-240 in urine 
(Figure 5) (Marchetti et al., 2002). An independent report on the results of this 
intercomparison exercise was recently published in the open scientific literature 
(McCurdy et al., 2005). 
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Figure 5. Results of a NIST interlaboratory exercise on 
determination of plutonium-239 in synthetic urine in the 
microBecquerel (μBq) range. 
We also continue to test the performance of the technique by analyzing externally-
prepared quality control natural urine samples artificially spiked with known amounts of 
plutonium. The quality control samples are prepared under contract with the Oak Ridge 
National Laboratory and analyzed along with routine bioassay samples collected from 
the Marshall Islands. The activity concentration of plutonium-239 in the quality control 
samples is kept below 200 μBq in order to avoid possible cross-contamination problems, 
and the plutonium-240/plutonium-239 atom ratio approximates that observed in 
integrated worldwide fallout deposition, i.e., ~0.2. The results of the quality control 
analyses are sent to Oak Ridge National Laboratory researchers for review who, in 
return, prepare a data quality assurance report. All quality control data must pass ANSI 
13.30 performance criteria for accuracy and precision before acceptance of any routine 
bioassay measurement data. The average combined measurement bias and precision 
based on spiked quality samples analyzed through March 2004 were −1.2% and ±5.1% 
for plutonium-239, and +6.1% and ±10.3% for plutonium-240, respectively. The results of 
the plutonium-239 measurements are shown in Figure 6. Based on the results from 
these performance tests we consider that the methodologies employed under the 
Marshall Islands Urinalysis Program to represent the current state-of-the-art in the field. 
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Figure 6. Results of plutonium-239 measurements 
in externally-prepared natural matrix spiked quality 
control samples 
Plutonium Urinalysis Monitoring on Enewetak 
The Individual (de-identified) measurement data developed under the Marshall Islands 
Plutonium Urinalysis Monitoring Program on Enewetak Island are tabulated in Appendix 
I, TABLE 2.  
The bioassay sampling program on Enewetak Atoll has involved 4 periodic sample 
collections of 40 to 50 volunteers. At the request of the Enewetak-Ujelang Atoll Local 
Government priority has been given to collecting bioassay samples from three main 
cohorts; (1) agricultural workers, (2) Enewetak Island residents born during the 1950-60s 
at the peak of the nuclear test program in the Marshall Islands, and (3) those people who 
were born on the island and who remained as residents of Enewetak Atoll. 
The geometric mean in the urinary excretion of plutonium-239 by Enewetak residents 
during the period between 2001 and 2003 was ~0.2 μBq per 24-hour void (N = 196). No 
plutonium-239 was found (based on the geometric mean) in a comparable set of field 
blanks (N = 24) prepared and analyzed over the same period. A more detailed statistical 
analysis of these data will be given elsewhere (Bogen et al., 2006). 
Urinary excretion of plutonium from Marshallese populations will consist of a long-term 
baseline component from residual systemic burdens acquired from all previous 
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exposures plus any prompt (new) contributions (and eventual long-term excretion) 
resulting from  recently acquired systemic burdens of plutonium. It is reported that 
people living in the Northern Hemisphere have acquired sufficiently high systemic 
burdens of plutonium from exposure to global fallout contamination to produce urinary 
excretion rates of around 2-4 μBq per 24-h void (Boecker et al., 1991). Based on fission 
track analysis of urine samples collected by scientists from Brookhaven National 
Laboratory, the systematic deposition of plutonium from exposure to global fallout 
contamination in the Marshall Islands is estimated to produce background urinary 
excretion rates of plutonium of around 1-2 μBq per 24-h void (National Research 
Council, 2004) or about an order of magnitude higher than levels observed in our 
studies. Consequently, we believe that the more precise and higher quality bioassay 
data based on Accelerator Mass Spectrometry will provide a more accurate basis for 
assessing small incremental uptakes of plutonium in resettled populations. Similarly, the 
sensitivity of the method is such that we may be able to track long-term changes in the 
availability and transfer of plutonium through the marine and/or terrestrial pathways to 
man. 
The vast majority of the individual bioassay samples collected from Enewetak Island 
residents contained less than the critical level of plutonium to provide measurements 
with an acceptable level of precision and accuracy. Nonetheless, we can say that the 
systemic burden of plutonium in Enewetak residents is generally very low and well within 
the background range expected for people living elsewhere in the Northern. This would 
normally negate the necessity to assign doses to the individual measurements. 
However, for completeness, we attempt to assign a dose to all the measurement data 
using default assumptions (refer associated Technical Basis Document, Daniels et al., 
2006). 
The range of estimates for the committed effective dose equivalent from systemic 
burdens of plutonium measured in the Enewetak Atoll agricultural workers and island 
residents during measurement years between 2001 and 2003 are shown in Figure 7. 
The committed dose shown in summary graphics on this web page is the dose received 
over 70 years from the year of measurement; refer supporting documentation (Daniels et 
al., 2006, Appendix 3). Please note that the annualized dose criteria developed for 
remediation of radioactively contaminated sites (NCRP, 2004) is usually based on 
estimates of the total effective dose equivalent (TEDE) over 50 years and consists of the  
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Figure 7. Frequency distribution of the committed effective 
dose equivalent from measured urinary excretion of 
plutonium from Enewetak Island residents during the year 
of measurement (2001 thru. 2003). Summary graphics are 
based on committed dose received over 70 years from the 
year of measurement; refer supporting documentation 
(Daniels et al., 2006, Appendix 3).  
sum of the committed dose due to intakes of radionuclides during the measurement year 
(of which, plutonium is just one potential component) and the deep dose equivalent from 
external exposures in that year. 
Plans for the Future 
Some of the early urinary excretion data for plutonium in the Marshall Islands is of 
questionable quality because of the poor quantification sensitivity of the methods 
employed and/or general lack of adequate quality control. Consequently, we plan to 
expand the plutonium urinalysis program over the next two years to include monitoring 
studies of background urinary excretion rates on Utrōk Atoll.  
In addition, we plan to collect bioassay samples from Rongelap Island to establish a 
baseline for people resettling the island. After resettlement, any increase in the systemic 
burden of plutonium will result from very low-level chronic exposure to plutonium in food 
and/or soil or from inhalation of plutonium resuspended in the air. High quality baseline 
urinary excretion data will therefore be required to provide a measure against which all 
future urinalysis tests on this population can be compared. Such provisions should help 
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provide assurances to the resettled population that we will be able to adequately monitor 
the return of the population and assess any changes in the systemic uptake of plutonium 
associated with resettlement. Similarly, high quality baseline data for other resettled 
communities such as the Enewetak and Utrōk Atoll population groups will provide 
essential information in helping track and monitor potential long-term changes in 
exposure conditions, especially in relation to the remobilization and transfer of plutonium 
through the aquatic food chain or from other changes in land use patterns. 
MEASUREMENT DATA FROM THE INDIVIDUAL RADIOLOGICAL SURVEILLANCE 
PROGRAM 
Introduction | Individual Measurement Database
Introduction 
The individual (de-identified) measurement database developed for the Enewetak 
population group is accessible over the world-wide web (Figure 8; http://eed.llnl.gov/mi/); 
Enewetak Measurem ent Data
SELECT YOUR PERSONAL ID
Rongelap Measurem ent Data
(includes resettlem ent workers)
SELECT YOUR PERSONAL ID
Select Personal IDSelect Personal ID
Select Personal ID
Utrok Measurem ent Data Other Marshall Islander Measurem ent Data
SELECT YOUR PERSONAL ID SELECT YOUR PERSONAL ID
subm it
subm itsubm it
subm itSelect Personal ID
 
Figure 8. Layout of the menu to access measurement data from our whole 
body counting and plutonium urinalysis programs over the world-wide web 
(http://eed.llnl.gov/mi/). 
Whole-body counting provides a direct measure of the total amount of cesium-137 
present in the human body at the time of measurement. The amount of cesium-137 
detected is usually reported in activity units of kilo-Becequerel (kBq), where 1 kBq 
equals 1000 Bq and 1 Bq = 1 nuclear transformation per second (t s-1). The detection of 
plutonium-239 (239Pu) and plutonium-240 (240Pu) in bioassay (urine) samples indicates 
the presence of internally deposited (systemic) plutonium in the body. At Livermore, 
these measurements are performed using a state-of-the-art technology based on 
Accelerator Mass Spectrometry (AMS) (Brown et al., 2004; Hamilton et al., 2004; 2006). 
Under the Marshall Islands Plutonium Urinalysis Program, the urinary excretion of 
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plutonium from program volunteers is usually described in activity units, expressed as 
micro-Becquerel (μBq) of 239+240Pu (the sum of the 239Pu and 240Pu activity) excreted 
(lost) per day (d-1); where 1 μBq d-1 = 10–6 Bq d-1 and 1 Bq = 1 t s-1. 
Individual Measurement Database 
The website provides electronic access to verified whole body counting and plutonium 
urinalysis data developed under the Marshall Islands Radiological Surveillance Program 
at the Lawrence Livermore National Laboratory (2001-present). Please note that 
measurements data developed for Enewetak residents incorporates counts from any 
one our three whole body counting facilities and may include people from other 
affiliations with the exception of permanent residents from Rongelap and Utrōk Atolls. 
DOSIMETRIC DATA AND METHODOLOGY  
Introduction | Dosimetric Methodology 
Introduction 
The individual (de-identified) dosimetric database developed for the Enewetak 
population group is accessible over the world-wide web (Figure 9, http://eed.llnl.gov/mi/); 
Enewetak Dosim etric Data
SELECT YOUR PERSONAL ID
Rongelap Dosim etric  Data
(includes resettlem ent workers)
SELECT YOUR PERSONAL ID
Select Personal IDSelect Personal ID
Select Personal ID
Utrok Dosim etricData Other Marshall Islander Dosim etric Data
SELECT YOUR PERSONAL ID SELECT YOUR PERSONAL ID
subm it
subm itsubm it
subm itSelect Personal ID
 
Figure 9. Layout of the menu to access dosimetric data from our whole 
body counting and plutonium urinalysis programs over the world-wide web 
(http://eed.llnl.gov/mi/). 
In general, nuclear transformations emit energy and/or particles in the form of gamma 
rays, beta particles and alpha particles. Tissues in the human body may adsorb these 
emissions with the potential for any deposited energy to cause damage and disrupt 
biological function of cells. The general term used to quantify the extent of any health 
risk from radiation exposure is referred to as the dose. The equivalent dose is defined by 
the average absorbed dose in an organ or tissue weighed by the average quality factor 
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for the type and energy of the radiation causing the dose. The effective dose equivalent 
(as applied to the whole body) is the sum of the average dose equivalent for each tissue 
weighted by tissue weighing factors. The SI unit of effective dose equivalent is the joule 
per kilogram (J kg-1), named the sievert (Sv). The conventional unit often used by federal 
and state agencies in the United States is called a rem; 1 rem = 0.01 Sv.  
Based on measurements of the internally deposited 137Cs and/or the urinary excretion of 
plutonium, an estimate can be derived for either or both radionuclides of the annual 
number of nuclear transformations (t y-1) that occurred in the body during the 
measurement year. For both radionuclides, this result is the time integral of activity in the 
body of an individual normalized over a one-year measurement period. In addition to 
nuclear transformations occurring during the year of measurement, additional 
transformations may occur in the future due to the presence of residual activity in the 
body at the end of the measurement year. The number of transformations derived from 
the residual radioactivity is usually evaluated up to 50 y in the future (a conservative 
maximum as defined by the United States (U.S.) Environmental Protection Agency 
(EPA) for members of the public) resulting in a committed dose. Accordingly, these 
future transformations will commit additional dose to the individual according to the 
biological half-life of the radioactive element of concern. For this reason, it is considered 
appropriate and conforming with the national and international recommendations of the 
United States Environment Protection Agency (U.S. EPA) and the International 
Commission on Radiological Protection (ICRP) that this additional dose commitment be 
assigned to the year of measurement. Consequently, dose reports issued under the 
Marshall Islands Radiological Surveillance Program are based on the Committed 
Effective Dose Equivalent (CEDE). 
Dosimetric Methodology 
The calendar year dose represents the sum of radionuclide-specific, age-dependent, 
committed effective dose equivalent for each monitored radionuclide. The total calendar 
years dose is calculated over a calendar year but only applies to the sum of the 
committed dose from cesium-137 and the 50-y integrated dose from plutonium (based 
on a time integral of any whole body counting and any available plutonium bioassay 
measurements performed during that year). When only one radionuclide is measured, 
the total dose assigned in a year and the CEDE for a specific radionuclide are identical. 
When more than one radionuclide is measured, the total annual ‘calendar year’ dose is 
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the sum on the CEDE for each measured radionuclide. The calendar year dose 
estimates based on whole body counting and plutonium bioassay are conservative in 
nature, especially in relation to plutonium, and is only be comparable to the internal dose 
component of the EDE standard of 15 mrem per year as adopted by the Marshall Islands 
Nuclear Claims Tribunal for cleanup and rehabilitation of radioactively contaminated 
sites (to view the full report on the dose methodology, see Daniels et al., 2006). 
PROVIDING FOLLOWUP ON RESULTS
All volunteers participating in the Marshall Islands Radiological Surveillance Program are 
issued a preliminary copy of their dose report immediately after they receive a whole 
body count. Scientists from the Lawrence Livermore National Laboratory verify the 
measurement data and, if required, issue a revised dose report. Annualized doses of 
0.10 mSv (10 mrem) or above will normally evoke a pre-determined action or 
investigation for the particular radionuclide concerned. These actions may include follow-
up verification measurements, a dietary evaluation and/or a work history review. Below 
this level, default assumptions for assigning doses (Daniels et al., 2006) are assumed to 
be valid and no further action is taken. Data may be withheld from the website or hard 
copy reports while these investigations are on-going. Our action level is one-tenth of the 
investigation level used throughout the U.S. Department of Energy and is well below the 
15 mrem per year standard adopted by the Republic of the Marshall Islands Nuclear 
Claims Tribunal for cleanup of radioactively contaminated sites. In addition, at the end of 
each calendar year, all program volunteers receive a final written report containing an 
estimate of their “calendar year dose” based on available data for the measurements 
year. 
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GLOSSARY OF TERMS 
Absorbed Dose 
The absorbed dose is the energy deposited in an organ or tissue per unit mass of 
irradiated material. The common unit for absorbed dose is the rad, which is equivalent to 
100 egs per gram of material. The international scientific community has adopted the 
use of different terms. The SI unit of absorbed dose is the joule per kilogram (J kg−1) 
and its special name is the gray (Gy). One Gy is the same as 100 rad. 
Activity 
Activity is the rate of transformation or decay of a radioactive material. The SI unit of 
activity is the reciprocal second (s−1) and its special name is the Becquerel. Federal and 
state agencies in the United States use conventional units where activity is given in 
curies (Ci); 1 Ci = 3.7 x 1010 Bq. 
Alpha Particles 
Alpha particles are one of the primary types of radiation associated with radioactivity and 
exist as energetic nuclei of helium atoms, consisting of two protons and two neutrons. 
Alpha rays are heavy, slow moving, charged particles that travel only one or two inches 
in air, and can be stopped by a piece of paper or the outer dead layer of human skin.  
Background Radiation  
The average person in the United States receives about 3.6 mSv (360 mrem) of ionizing 
radiation every year. About 3.0 mSv (300 mrem) per year comes from natural 
background radiation including cosmic radiation, radiation emitted by naturally occurring 
radionuclides in air, water, soil and rock, and radiation emitted by natural radionuclides 
deposited in tissues of organs; and  about (0.6 mSv) 60 mrem from man-made sources 
such as exposures to diagnostic X-rays and consumer products (e.g., from smoking 
tobacco). The general worldwide contribution from radioactive fallout contamination is 
<0.3% of the average total annual dose. Exposures to natural background radiation vary 
depending on the geographic area, diet and other factors such as the composition of 
materials used in the construction of homes. The natural background radiation dose in 
the Marshall Islands is around 1.4 mSv (140 mrem) per year and is significantly less 
than what most people receive around the world. 
Baseline 
We have all been exposed to some level of worldwide fallout contamination. In the 
United States, the general population receives up to 0.015 mSv (1.5 mrem) or about 
0.3% of the average total annual dose from exposure to worldwide fallout contamination 
from atmospheric nuclear weapons testing and about 0.005 (0.5 mrem) or about 0.1% of 
the average total annual dose from operations related nuclear power generation. 
Similarly, people living in the Marshall Islands will have very small quantities of internally 
deposited fallout radionuclides such as cesium-137, strontium-90 and plutonium in their 
bodies from worldwide contamination of food, air, water and soil. Assessments of 
possible increases in radiation exposure from elevated levels of fallout contamination in 
the northern Marshall Islands can only be made on the basis of comparisons with 
residual systematic burdens of radionuclides acquired from previous exposures to global 
fallout contamination. Under the Marshall Islands Radiological Surveillance Program, 
efforts are being made to improve on the reliability of measurements of background 
urinary excretion rates of plutonium from Marshallese populations against which the 
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results of future bioassay measurements can be compared to accurately assess the 
impacts of resettlement on radiation exposure and dose. 
Becquerel (Bq) 
A Becquerel (abbreviated as Bq) is the International System (SI) unit for activity of 
radioactive material. One Bq of radioactive material is that amount of material in which 
one atom is transformed or undergoes 1 disintegration every second. Whole body 
counting and plutonium bioassay measurements are usually reported in activity units of 
kBq (kiloBecquerel) (1000 x 1 Bq) and μBq (microBecquerel) (1×10−6 x 1 Bq), 
respectively. 
Biokinectic 
The word ‘biokinectic’ is used here to describe the adsorption (uptake), distribution and 
retention of elements in humans.   
Calibration 
Calibration is the process of adjusting or determining the response or reading of an 
instrument to a standard.   
Committed Dose Equivalent 
Committed dose equivalent is the time integral of the dose-equivalent rate in a particular 
tissue that will be received by an individual following an intake of radioactive material 
into the body by inhalation, ingestion or dermal absorption. For adults the committed 
dose is usually the dose received over 50 years. For children, the committed dose is 
usually calculated from the age of intake to age 70 years. For these age groups the term 
‘integrated dose equivalent’ is used. 
Committed Effective Dose Equivalent (CEDE) 
The committed effective dose equivalent is the committed dose equivalents to various 
tissues or organ in the body each multiplied by an appropriate tissue-weighing factor and 
then summed. The conventional unit for committed effective dose equivalence (CEDE) 
used by federal and state agencies within the United States is the rem. The international 
scientific (SI) unit of committed effective dose equivalent is called a sievert (Sv). One Sv 
is the same as 100 rem. 
Critical Level (Lc) 
The critical level is the amount of a count or final measurement of a quantity of an 
analyte at or above which a decision is made that the analyte is definitely present (Lc ≈ 
MDA/2). 
Default Assumptions (used in assignment of dose) 
The largest dose contributions attributable to exposure to residual nuclear fallout 
contamination in the Marshall Islands result from either internal exposure from intakes of 
radionuclides through ingestion, inhalation and/or absorption through the skin or external 
exposure from radionuclides distributed in the soil. External exposure rates can be 
measured directly using instrument surveys of the radiation field. The assignment of 
dose to internally deposited radionuclides is much more complicated. Biokinectic and 
dosimetric models developed by the International Commission on Radiological 
Protection (ICRP) are used to convert whole body burdens (from whole body counting or 
from in vitro bioassay tests such as urinalysis) into dose. In the case of a chronic 
exposure, organ and body burdens continue to build up over time until a steady state is 
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reached where losses due to decay and excretion are balanced by intake and 
absorption. Cesium-137 has an effective half-life in an adult of about 110 days, and 
under chronic exposure conditions reaches a maximal dose contribution after about 2 
years. By contrast, plutonium absorbed from the gastrointestinal or respiratory tract 
enters the blood stream and deposits in liver and bone with an effective half-life of 20 to 
50 years. Only a small fraction of plutonium entering the blood stream is excreted in 
urine with the long-term excretion rate approaching 2 x 10−5 of the systemic body 
burden per day. Knowledge of excretion rates and time of exposure are important when 
interpreting urinalysis data. A more detailed discussion of the dose calculation 
methodology is given elsewhere (see under Daniels et al., 2006). 
Direct bioassay 
The measurements of radioactive material in the human body utilizing instrumentation 
that detects radiation emitted from radioactive material in the body (synonymous with in 
vivo measurements).  
Dose Assessment 
The scientific process used to determine radiation dose and uncertainty in the dose.  
Dose Equivalent 
The dose equivalent is the adsorbed dose at a point in tissue multiplied by a biological 
effectiveness factor or quality factor for the particular types of radiation to cause 
biological damage. The conventional unit of dose equivalents used by federal and state 
agencies in the United States is the rem. A dose of 100 rem to an adult normally 
produces some clinical signs of radiation sickness and requires hospitalization. The 
international scientific unit for dose equivalent is the joule per kilogram (J kg−1) and is 
called the sievert (Sv). One Sv is the same as 100 rem. 
Effective Dose Equivalent 
The effective dose equivalent for the whole body is the sum of dose-equivalents for 
various organs in the body weighted to account for different sensitivities of the organs to 
radiation. It includes the dose from radiation sources internal and/or external to the body.  
The effective dose equivalent is usually expressed in units of millirem (mrem). The 
international scientific unit for dose equivalent is the joule per kilogram (J kg−1) and is 
called the sievert (Sv). One Sv is the same as 100 rem. 
External Dose or Exposure 
That portion of the dose equivalent received from radiation sources outside the human 
body. 
Fission Track Analysis 
During neutron irradiation heavy nuclei such as uranium and plutonium undergo nuclear 
fission with release of large fission fragments. This property has led to the development 
of a number of measurement techniques such as delayed neutron activation analysis 
and fission track analysis. Fission track analysis is a measurement technique commonly 
employed in plutonium urinalysis (bioassay) monitoring programs. Urine samples are 
chemically treated to remove plutonium. The plutonium is then mounted in contact with a 
special plastic or quartz slide known as solid-state nuclear track detector (SSNTD). The 
slide along with the sample is then irradiated in a reactor where neutron-induced fission 
of plutonium-239 (or uranium-235) causes emission of energetic fission fragments. 
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Some of the fragments penetrate into the SSNTD damaging the integrity of the material 
before coming to rest. The SSNTD is separated from the sample and chemically etched 
to expose the damaged areas (known as fission tracks) on the detector surface. The 
fission tracks are then counted under an optical microscope. The amount of plutonium 
(and/or uranium) present in the sample is a function of the total number of tracks and the 
neutron flux. 
Gamma-rays 
Gamma-rays are electromagnetic waves produced by spontaneous decay of radioactive 
elements during de-excitation of an atomic nucleus. Sunlight also consists of 
electromagnetic waves but gamma-rays have a shorter wavelength and much higher 
energy. High-energy gamma-rays such as those produced by decay of cesium-137 may 
penetrate deeply into the body and affect cells. Gamma-rays from a cobalt-60 source are 
often used for cancer radiotherapy. 
High-End Health Risk 
High-end health risk is used here under the context that it refers to the maximally 
exposed individuals in a population. 
In Vito 
In vitro measurements are synonymous with indirect bioassay techniques, such as 
plutonium urinalysis. 
In Vivo 
In vivo measurements are synonymous with bioassay techniques, such as whole body 
counting.  
Indirect bioassay 
In direct bioassay are measurements used to determine the presence of and/or the 
amount of a radioactive material in the excreta, urine or in other biological materials 
removed from the body (synonymous with in vitro measurements). 
Individual 
An individual is any human being. 
Internal Dose or Exposure  
The internal dose is that portion of the dose equivalent received from radiation sources 
inside the human body. 
Isotope 
Atoms with the same number of protons but different numbers of neutrons are called 
isotopes of that element. We identify different isotopes by appending the total number of 
nucleons (the total number of proton plus neutrons in the nucleus of an atom) to the 
name of the element, e.g., cesium-137. Isotopes are usually written in an abbreviated 
form using the chemical symbol of the element. Two examples include 137Cs for 
cesium-137 and 239Pu for plutonium-239.   
Minimum Detectable Amount (MDA) 
The minimum detectable amount (MDA) is the smallest activity or mass of an analyte in 
a sample or person that can be detected with an acceptable level of uncertainty. 
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Quality Assurance 
All those planned and systematic actions necessary to provide adequate confidence that 
an analysis, measurement or surveillance program will perform satisfactorily. 
Quality Control 
Quality Control is defined as those actions taken to control the attributes of a analytical 
process, system or facility according to predetermined quality requirements. 
Radiation Dose (or mrem)
A generic term to describe the amount of radiation a person receives. Dose is measured 
in units of thousands of a roentegen equivalent man (rem) (called the millirem). The 
conventional unit used by federal and state agencies in the United States is the millirem 
(mrem). Dose is a general term used to assist in the management of exposure to 
radiation. The common international scientific (SI) unit for dose is the millisievert (mSv). 
One mSv is the same as 100 mrem. 
Radioactivity 
A natural and spontaneous process by which unstable atoms of an element emit energy 
and/or particles from their nuclei and, thus change (or decay) to atoms of a different 
element or a different state of the same element. 
Radiological Monitoring 
Radiological monitoring is the process of measuring radiation levels or individual doses, 
and the use of the results to assess radiological hazards or potential and actual doses 
resulting from exposures to ionizing radiation. 
Remediation 
Remediation is the actions taken to reduce risks to human health or the environment 
posed by the presence of radioactive or hazardous materials. 
Risk 
The probability of harm from the presence of radionuclides or hazardous materials taking 
into account (1) the probability of occurrences or events that could lead to an exposure, 
(2) probability that individual or populations would be exposed to radioactive or 
hazardous materials and the magnitude of such exposures, and (3) the probability that 
an exposure would produce a response.  
Validation 
Validation refers to the process of defining the method capability and determining 
whether it can be properly applied as intended. 
Whole Body 
For the purposes of external exposure includes the head, trunk, the arms above and 
including the elbow, and legs above and including the knee.  
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Date Value MDA 
 
EN00002 Adult Male 2002-02-08 0.28 ± 0.02 0.10 
EN00002 Adult Male 2002-06-03 0.38 ± 0.02 0.10 
EN00002 Adult Male 2003-09-04 0.30 ± 0.02 0.18 
EN00003 Adult Male 2002-04-02 0.20 ± 0.02 0.10 
EN00003 Adult Male 2003-07-19 0.36 ± 0.02 0.18 
EN00003 Adult Male 2004-03-02 0.40 ± 0.03 0.15 
EN00003 Adult Male 2004-07-15 0.34 ± 0.07 0.31 
EN00003 Adult Male 2004-08-26 0.11 ± 0.04 0.19 
EN00004 Adult Male 2002-02-11 0.06 ± 0.01 0.08 
EN00004 Adult Male 2002-05-23 0.00 ± 0.00 0.06 
EN00004 Adult Male 2002-06-24 0.00 ± 0.00 0.06 
EN00004 Adult Male 2002-10-03 0.11 ± 0.01 0.08 
EN00004 Adult Male 2004-01-12 0.00 ± 0.00 0.07 
EN00004 Adult Male 2004-02-10 0.00 ± 0.00 0.07 
EN00004 Adult Male 2004-07-22 0.04 ± 0.02 0.09 
EN00004 Adult Male 2004-09-30 0.04 ± 0.02 0.08 
EN00004 Adult Male 2004-12-02 0.00 ± 0.00 0.06 
EN00005 Adult Male 2002-02-11 0.21 ± 0.02 0.09 
EN00005 Adult Male 2002-03-14 0.20 ± 0.02 0.09 
EN00005 Adult Male 2002-05-24 0.25 ± 0.02 0.10 
EN00005 Adult Male 2002-06-24 0.30 ± 0.02 0.10 
EN00005 Adult Male 2002-12-04 0.33 ± 0.02 0.11 
EN00005 Adult Male 2004-01-12 0.08 ± 0.02 0.18 
EN00005 Adult Male 2004-02-11 0.06 ± 0.01 0.17 
EN00005 Adult Male 2004-07-26 0.18 ± 0.03 0.13 
EN00006 Adult Male 2002-02-13 0.24 ± 0.02 0.08 
EN00006 Adult Male 2002-03-15 0.15 ± 0.01 0.09 
EN00006 Adult Male 2002-05-23 0.36 ± 0.02 0.10 
EN00006 Adult Male 2002-06-24 0.39 ± 0.02 0.10 
EN00006 Adult Male 2002-10-03 0.38 ± 0.02 0.11 
EN00006 Adult Male 2002-11-27 0.27 ± 0.02 0.11 
EN00006 Adult Male 2003-01-08 0.26 ± 0.02 0.10 
EN00006 Adult Male 2003-11-19 0.00 ± 0.00 0.08 
EN00006 Adult Male 2004-01-12 0.07 ± 0.02 0.19 
EN00006 Adult Male 2004-06-21 0.44 ± 0.04 0.17 
EN00006 Adult Male 2004-07-28 0.35 ± 0.03 0.14 
EN00006 Adult Male 2004-09-30 0.29 ± 0.03 0.14 
EN00007 Adult Male 2002-02-11 0.64 ± 0.04 0.11 
EN00007 Adult Male 2002-03-14 0.51 ± 0.03 0.11 
EN00007 Adult Male 2002-05-23 0.50 ± 0.03 0.11 
EN00007 Adult Male 2002-06-25 0.46 ± 0.03 0.10 
EN00007 Adult Male 2002-10-08 0.36 ± 0.02 0.11 
EN00007 Adult Male 2002-11-27 0.27 ± 0.02 0.10 
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EN00007 Adult Male 2003-12-02 0.16 ± 0.02 0.31 
EN00007 Adult Male 2004-01-12 0.00 ± 0.00 0.08 
EN00007 Adult Male 2004-02-10 0.00 ± 0.00 0.08 
EN00007 Adult Male 2004-06-21 0.14 ± 0.03 0.13 
EN00007 Adult Male 2004-07-21 0.24 ± 0.04 0.16 
EN00007 Adult Male 2004-12-02 0.00 ± 0.00 0.06 
EN00008 Adult Male 2002-02-11 0.16 ± 0.01 0.10 
EN00008 Adult Male 2002-03-14 0.13 ± 0.01 0.09 
EN00009 Adult Male 2002-02-18 0.08 ± 0.01 0.09 
EN00009 Adult Male 2002-03-19 0.07 ± 0.01 0.09 
EN00009 Adult Male 2002-05-23 0.14 ± 0.01 0.09 
EN00009 Adult Male 2002-06-25 0.08 ± 0.01 0.09 
EN00009 Adult Male 2002-10-04 0.16 ± 0.01 0.08 
EN00009 Adult Male 2002-11-25 0.09 ± 0.01 0.10 
EN00009 Adult Male 2003-01-07 0.10 ± 0.01 0.08 
EN00009 Adult Male 2003-11-19 0.00 ± 0.00 0.07 
EN00009 Adult Male 2004-01-09 0.13 ± 0.01 0.26 
EN00009 Adult Male 2004-02-10 0.09 ± 0.02 0.13 
EN00009 Adult Male 2004-06-21 0.06 ± 0.02 0.09 
EN00009 Adult Male 2004-07-22 0.08 ± 0.02 0.09 
EN00009 Adult Male 2004-09-30 0.04 ± 0.02 0.07 
EN00010 Adult Male 2002-02-13 0.18 ± 0.02 0.10 
EN00010 Adult Male 2002-03-22 0.13 ± 0.01 0.10 
EN00010 Adult Male 2002-05-23 0.23 ± 0.02 0.09 
EN00010 Adult Male 2002-06-24 0.24 ± 0.02 0.10 
EN00010 Adult Male 2002-10-03 0.34 ± 0.02 0.11 
EN00010 Adult Male 2003-01-07 0.21 ± 0.02 0.11 
EN00010 Adult Male 2003-12-01 0.16 ± 0.02 0.16 
EN00010 Adult Male 2004-01-12 0.09 ± 0.02 0.19 
EN00010 Adult Male 2004-02-10 0.11 ± 0.02 0.17 
EN00010 Adult Male 2004-06-21 0.40 ± 0.02 0.19 
EN00010 Adult Male 2004-07-22 0.35 ± 0.03 0.14 
EN00011 Adult Male 2002-02-11 0.24 ± 0.02 0.08 
EN00011 Adult Male 2002-05-24 0.26 ± 0.02 0.10 
EN00011 Adult Male 2002-06-24 0.24 ± 0.02 0.10 
EN00011 Adult Male 2002-10-03 0.26 ± 0.02 0.10 
EN00011 Adult Male 2002-11-25 0.26 ± 0.02 0.10 
EN00011 Adult Male 2003-01-06 0.22 ± 0.02 0.11 
EN00011 Adult Male 2003-11-26 0.11 ± 0.02 0.16 
EN00011 Adult Male 2004-01-12 0.31 ± 0.02 0.19 
EN00011 Adult Male 2004-02-10 0.37 ± 0.02 0.17 
EN00011 Adult Male 2004-07-22 0.49 ± 0.04 0.18 
EN00012 Adult Male 2002-02-11 0.06 ± 0.01 0.08 
EN00012 Adult Male 2002-03-15 0.07 ± 0.01 0.10 
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EN00012 Adult Male 2002-05-23 0.09 ± 0.01 0.09 
EN00012 Adult Male 2002-06-24 0.07 ± 0.01 0.08 
EN00012 Adult Male 2002-10-04 0.09 ± 0.01 0.09 
EN00012 Adult Male 2002-11-27 0.16 ± 0.01 0.08 
EN00012 Adult Male 2003-01-07 0.15 ± 0.01 0.08 
EN00012 Adult Male 2003-12-01 0.22 ± 0.02 0.16 
EN00012 Adult Male 2004-01-12 0.14 ± 0.02 0.18 
EN00012 Adult Male 2004-02-10 0.12 ± 0.02 0.16 
EN00012 Adult Male 2004-06-21 0.23 ± 0.04 0.19 
EN00012 Adult Male 2004-07-29 0.18 ± 0.04 0.18 
EN00013 Adult Male 2002-02-18 0.06 ± 0.01 0.07 
EN00013 Adult Male 2002-03-18 0.00 ± 0.00 0.06 
EN00013 Adult Male 2002-05-23 0.00 ± 0.00 0.06 
EN00013 Adult Male 2002-06-24 0.08 ± 0.01 0.07 
EN00013 Adult Male 2003-01-07 0.00 ± 0.00 0.07 
EN00013 Adult Male 2003-12-01 0.06 ± 0.01 0.13 
EN00013 Adult Male 2004-01-12 0.00 ± 0.00 0.07 
EN00013 Adult Male 2004-02-10 0.00 ± 0.00 0.07 
EN00015 Adult Male 2002-02-11 0.10 ± 0.01 0.08 
EN00015 Adult Male 2002-03-18 0.09 ± 0.01 0.09 
EN00015 Adult Male 2002-05-23 0.15 ± 0.01 0.09 
EN00015 Adult Male 2002-06-24 0.15 ± 0.01 0.10 
EN00015 Adult Male 2002-10-04 0.16 ± 0.01 0.10 
EN00015 Adult Male 2003-01-06 0.13 ± 0.01 0.08 
EN00015 Adult Male 2003-12-01 0.09 ± 0.01 0.15 
EN00015 Adult Male 2004-01-09 0.07 ± 0.01 0.15 
EN00015 Adult Male 2004-02-10 0.00 ± 0.00 0.08 
EN00015 Adult Male 2004-06-21 0.14 ± 0.02 0.11 
EN00015 Adult Male 2004-07-23 0.10 ± 0.02 0.11 
EN00016 Adult Male 2003-11-19 0.00 ± 0.00 0.08 
EN00018 Adult Male 2002-02-13 0.12 ± 0.01 0.09 
EN00018 Adult Male 2002-03-18 0.15 ± 0.01 0.09 
EN00018 Adult Male 2002-05-24 0.24 ± 0.02 0.11 
EN00018 Adult Male 2002-06-24 0.26 ± 0.02 0.10 
EN00018 Adult Male 2002-10-04 0.39 ± 0.02 0.11 
EN00018 Adult Male 2002-11-27 0.27 ± 0.02 0.11 
EN00018 Adult Male 2003-01-06 0.22 ± 0.02 0.11 
EN00018 Adult Male 2003-12-02 0.00 ± 0.00 0.08 
EN00018 Adult Male 2004-01-12 0.09 ± 0.02 0.17 
EN00018 Adult Male 2004-02-11 0.08 ± 0.01 0.17 
EN00018 Adult Male 2004-06-21 0.21 ± 0.04 0.16 
EN00018 Adult Male 2004-07-22 0.26 ± 0.03 0.13 
EN00019 Adult Male 2002-02-11 0.22 ± 0.02 0.11 
EN00019 Adult Male 2002-03-18 0.11 ± 0.01 0.08 
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EN00019 Adult Male 2002-05-23 0.25 ± 0.02 0.10 
EN00019 Adult Male 2002-06-24 0.25 ± 0.02 0.10 
EN00019 Adult Male 2002-10-04 0.36 ± 0.02 0.11 
EN00020 Adult Male 2002-02-13 0.24 ± 0.02 0.10 
EN00020 Adult Male 2002-05-23 0.40 ± 0.02 0.10 
EN00020 Adult Male 2003-12-01 0.14 ± 0.02 0.16 
EN00020 Adult Male 2004-01-12 0.15 ± 0.02 0.19 
EN00020 Adult Male 2004-02-10 0.20 ± 0.02 0.16 
EN00020 Adult Male 2004-06-24 0.23 ± 0.04 0.17 
EN00020 Adult Male 2004-07-22 0.18 ± 0.04 0.16 
EN00021 Adult Male 2002-02-13 0.16 ± 0.01 0.08 
EN00021 Adult Male 2002-03-15 0.08 ± 0.01 0.09 
EN00021 Adult Male 2002-05-24 0.25 ± 0.02 0.10 
EN00021 Adult Male 2002-06-25 0.24 ± 0.02 0.09 
EN00021 Adult Male 2002-12-04 0.58 ± 0.03 0.11 
EN00021 Adult Male 2003-01-07 0.50 ± 0.03 0.12 
EN00021 Adult Male 2003-11-27 0.29 ± 0.02 0.17 
EN00021 Adult Male 2004-01-12 0.32 ± 0.02 0.18 
EN00021 Adult Male 2004-02-10 0.26 ± 0.02 0.17 
EN00021 Adult Male 2004-06-21 0.58 ± 0.04 0.17 
EN00021 Adult Male 2004-07-28 0.42 ± 0.07 0.32 
EN00022 Adult Male 2002-02-19 0.10 ± 0.01 0.09 
EN00022 Adult Male 2002-03-15 0.12 ± 0.01 0.08 
EN00022 Adult Male 2002-06-25 0.06 ± 0.01 0.08 
EN00022 Adult Male 2002-12-04 0.16 ± 0.01 0.10 
EN00022 Adult Male 2003-01-14 0.20 ± 0.01 0.08 
EN00022 Adult Male 2003-11-19 0.07 ± 0.01 0.15 
EN00022 Adult Male 2004-01-13 0.05 ± 0.01 0.12 
EN00022 Adult Male 2004-02-10 0.10 ± 0.02 0.16 
EN00022 Adult Male 2004-06-23 0.21 ± 0.03 0.12 
EN00022 Adult Male 2004-07-26 0.22 ± 0.03 0.12 
EN00023 Adult Male 2002-02-19 0.15 ± 0.01 0.09 
EN00023 Adult Male 2002-06-03 0.23 ± 0.02 0.10 
EN00023 Adult Male 2002-10-08 0.33 ± 0.02 0.11 
EN00023 Adult Male 2002-11-27 0.23 ± 0.02 0.11 
EN00023 Adult Male 2003-01-06 0.17 ± 0.01 0.11 
EN00023 Adult Male 2004-01-14 0.14 ± 0.02 0.18 
EN00023 Adult Male 2004-02-10 0.15 ± 0.02 0.16 
EN00023 Adult Male 2004-06-23 0.13 ± 0.03 0.13 
EN00023 Adult Male 2004-07-22 0.15 ± 0.03 0.12 
EN00024 Adult Male 2002-03-18 0.55 ± 0.03 0.11 
EN00024 Adult Male 2002-05-24 0.60 ± 0.03 0.11 
EN00024 Adult Male 2002-06-25 0.54 ± 0.03 0.11 
EN00024 Adult Male 2002-10-08 0.60 ± 0.03 0.12 
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EN00024 Adult Male 2002-12-02 0.47 ± 0.02 0.11 
EN00024 Adult Male 2003-01-08 0.47 ± 0.02 0.11 
EN00024 Adult Male 2003-11-26 0.30 ± 0.02 0.16 
EN00024 Adult Male 2004-01-12 0.28 ± 0.02 0.19 
EN00024 Adult Male 2004-02-10 0.28 ± 0.02 0.17 
EN00024 Adult Male 2004-06-23 0.47 ± 0.04 0.15 
EN00024 Adult Male 2004-07-23 0.49 ± 0.07 0.33 
EN00024 Adult Male 2004-07-23 0.66 ± 0.08 0.36 
EN00025 Adult Male 2002-02-18 0.13 ± 0.01 0.09 
EN00025 Adult Male 2002-03-22 0.13 ± 0.01 0.09 
EN00025 Adult Male 2002-05-27 0.25 ± 0.02 0.09 
EN00025 Adult Male 2002-06-25 0.32 ± 0.02 0.10 
EN00025 Adult Male 2002-10-08 0.26 ± 0.02 0.11 
EN00025 Adult Male 2002-11-25 0.23 ± 0.02 0.09 
EN00025 Adult Male 2003-01-08 0.17 ± 0.01 0.10 
EN00025 Adult Male 2003-12-01 0.14 ± 0.02 0.16 
EN00025 Adult Male 2004-01-14 0.09 ± 0.02 0.16 
EN00025 Adult Male 2004-06-21 0.44 ± 0.04 0.16 
EN00025 Adult Male 2004-07-23 0.00 ± 0.00 0.13 
EN00027 Adult Male 2002-02-18 0.06 ± 0.01 0.10 
EN00027 Adult Male 2002-03-15 0.08 ± 0.01 0.08 
EN00027 Adult Male 2002-05-27 0.08 ± 0.01 0.09 
EN00027 Adult Male 2002-06-25 0.11 ± 0.01 0.07 
EN00027 Adult Male 2002-10-08 0.33 ± 0.02 0.11 
EN00027 Adult Male 2002-11-27 0.23 ± 0.02 0.11 
EN00027 Adult Male 2003-01-07 0.21 ± 0.02 0.11 
EN00027 Adult Male 2003-12-01 0.14 ± 0.02 0.28 
EN00027 Adult Male 2004-01-13 0.08 ± 0.02 0.16 
EN00027 Adult Male 2004-02-10 0.00 ± 0.00 0.07 
EN00027 Adult Male 2004-06-24 0.08 ± 0.02 0.10 
EN00027 Adult Male 2004-07-22 0.00 ± 0.00 0.06 
EN00028 Adult Male 2002-02-19 0.12 ± 0.01 0.10 
EN00028 Adult Male 2002-03-20 0.11 ± 0.01 0.08 
EN00028 Adult Male 2002-05-29 0.14 ± 0.01 0.10 
EN00028 Adult Male 2002-06-25 0.19 ± 0.02 0.10 
EN00028 Adult Male 2002-12-04 0.16 ± 0.01 0.09 
EN00029 Adult Male 2002-02-19 0.12 ± 0.01 0.09 
EN00029 Adult Male 2002-03-19 0.11 ± 0.01 0.10 
EN00029 Adult Male 2002-05-27 0.19 ± 0.02 0.10 
EN00029 Adult Male 2002-06-26 0.21 ± 0.02 0.09 
EN00029 Adult Male 2002-10-08 0.25 ± 0.02 0.11 
EN00029 Adult Male 2002-11-25 0.17 ± 0.01 0.09 
EN00029 Adult Male 2003-11-19 0.00 ± 0.00 0.08 
EN00029 Adult Male 2003-11-26 0.00 ± 0.00 0.08 
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EN00029 Adult Male 2004-01-14 0.07 ± 0.02 0.18 
EN00029 Adult Male 2004-02-11 0.08 ± 0.01 0.17 
EN00029 Adult Male 2004-06-23 0.41 ± 0.04 0.19 
EN00029 Adult Male 2004-07-26 0.24 ± 0.03 0.16 
EN00030 Adult Male 2002-07-02 0.15 ± 0.01 0.10 
EN00032 Adult Male 2002-02-13 0.14 ± 0.01 0.09 
EN00032 Adult Male 2002-03-22 0.12 ± 0.01 0.09 
EN00032 Adult Male 2002-06-26 0.13 ± 0.01 0.09 
EN00032 Adult Male 2002-10-08 0.19 ± 0.02 0.10 
EN00032 Adult Male 2002-11-25 0.16 ± 0.01 0.09 
EN00032 Adult Male 2003-01-07 0.13 ± 0.01 0.10 
EN00032 Adult Male 2003-11-19 0.19 ± 0.02 0.16 
EN00032 Adult Male 2004-01-13 0.25 ± 0.02 0.18 
EN00032 Adult Male 2004-02-10 0.19 ± 0.02 0.17 
EN00032 Adult Male 2004-07-26 0.13 ± 0.03 0.13 
EN00032 Adult Male 2004-12-02 0.08 ± 0.03 0.15 
EN00033 Adult Male 2002-02-19 0.16 ± 0.01 0.08 
EN00033 Adult Male 2002-03-14 0.10 ± 0.01 0.09 
EN00033 Adult Male 2002-05-27 0.19 ± 0.02 0.09 
EN00033 Adult Male 2002-06-26 0.22 ± 0.02 0.10 
EN00033 Adult Male 2002-10-09 0.22 ± 0.02 0.10 
EN00033 Adult Male 2002-12-04 0.15 ± 0.01 0.09 
EN00033 Adult Male 2003-01-09 0.12 ± 0.01 0.09 
EN00033 Adult Male 2004-01-09 0.08 ± 0.02 0.16 
EN00033 Adult Male 2004-02-10 0.08 ± 0.01 0.17 
EN00033 Adult Male 2004-06-23 0.15 ± 0.03 0.12 
EN00033 Adult Male 2004-07-22 0.16 ± 0.03 0.14 
EN00033 Adult Male 2004-09-30 0.10 ± 0.03 0.13 
EN00034 Adult Male 2002-02-11 0.23 ± 0.02 0.10 
EN00034 Adult Male 2002-03-18 0.18 ± 0.02 0.10 
EN00034 Adult Male 2002-05-27 0.35 ± 0.02 0.10 
EN00034 Adult Male 2002-06-26 0.37 ± 0.02 0.10 
EN00034 Adult Male 2003-01-08 0.22 ± 0.02 0.10 
EN00034 Adult Male 2003-12-01 0.15 ± 0.02 0.16 
EN00034 Adult Male 2004-01-14 0.16 ± 0.02 0.17 
EN00034 Adult Male 2004-02-10 0.19 ± 0.02 0.17 
EN00034 Adult Male 2004-06-24 0.28 ± 0.04 0.17 
EN00034 Adult Male 2004-07-22 0.34 ± 0.03 0.15 
EN00034 Adult Male 2004-09-30 0.17 ± 0.03 0.15 
EN00035 Adult Male 2002-02-18 0.09 ± 0.01 0.10 
EN00035 Adult Male 2002-03-15 0.15 ± 0.01 0.07 
EN00035 Adult Male 2002-05-29 0.12 ± 0.01 0.08 
EN00035 Adult Male 2002-06-26 0.11 ± 0.01 0.08 
EN00035 Adult Male 2002-10-09 0.18 ± 0.01 0.10 
EN00035 Adult Male 2002-12-04 0.22 ± 0.02 0.10 
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EN00035 Adult Male 2003-01-14 0.15 ± 0.01 0.09 
EN00035 Adult Male 2004-01-15 0.26 ± 0.02 0.18 
EN00035 Adult Male 2004-02-11 0.21 ± 0.02 0.17 
EN00035 Adult Male 2004-07-22 0.19 ± 0.03 0.12 
EN00036 Adult Male 2003-12-02 0.14 ± 0.02 0.16 
EN00036 Adult Male 2004-06-01 0.19 ± 0.03 0.13 
EN00037 Adult Male 2002-07-02 0.19 ± 0.02 0.10 
EN00038 Adult Male 2002-02-18 0.16 ± 0.01 0.09 
EN00038 Adult Male 2002-05-27 0.22 ± 0.02 0.09 
EN00038 Adult Male 2002-06-25 0.25 ± 0.02 0.09 
EN00038 Adult Male 2002-12-04 0.32 ± 0.02 0.11 
EN00038 Adult Male 2003-01-09 0.31 ± 0.02 0.11 
EN00038 Adult Male 2003-11-26 0.32 ± 0.02 0.16 
EN00038 Adult Male 2004-01-13 0.34 ± 0.02 0.18 
EN00038 Adult Male 2004-02-10 0.25 ± 0.02 0.16 
EN00038 Adult Male 2004-07-21 0.79 ± 0.05 0.19 
EN00039 Adult Male 2002-02-18 0.20 ± 0.02 0.09 
EN00039 Adult Male 2002-03-18 0.21 ± 0.02 0.10 
EN00039 Adult Male 2002-05-27 0.21 ± 0.02 0.10 
EN00039 Adult Male 2002-06-26 0.20 ± 0.02 0.10 
EN00039 Adult Male 2002-10-09 0.23 ± 0.02 0.11 
EN00039 Adult Male 2002-12-04 0.16 ± 0.01 0.09 
EN00039 Adult Male 2003-01-08 0.25 ± 0.02 0.11 
EN00039 Adult Male 2003-12-01 0.16 ± 0.02 0.17 
EN00039 Adult Male 2004-01-14 0.17 ± 0.02 0.18 
EN00039 Adult Male 2004-02-11 0.22 ± 0.02 0.18 
EN00040 Adult Male 2002-07-02 0.12 ± 0.01 0.07 
EN00040 Adult Male 2003-11-28 0.00 ± 0.00 0.08 
EN00040 Adult Male 2004-03-24 0.26 ± 0.04 0.18 
EN00040 Adult Male 2004-05-31 0.25 ± 0.04 0.17 
EN00041 Adult Male 2003-12-02 0.13 ± 0.01 0.16 
EN00041 Adult Male 2004-08-26 0.43 ± 0.07 0.29 
EN00042 Adult Male 2002-02-18 0.19 ± 0.02 0.10 
EN00042 Adult Male 2002-03-15 0.18 ± 0.02 0.09 
EN00042 Adult Male 2002-06-03 0.55 ± 0.03 0.09 
EN00042 Adult Male 2002-06-27 0.43 ± 0.03 0.08 
EN00042 Adult Male 2003-01-08 0.38 ± 0.02 0.11 
EN00042 Adult Male 2003-12-01 0.23 ± 0.02 0.16 
EN00042 Adult Male 2004-01-09 0.28 ± 0.02 0.17 
EN00042 Adult Male 2004-02-10 0.37 ± 0.02 0.17 
EN00042 Adult Male 2004-06-24 0.41 ± 0.04 0.19 
EN00043 Adult Male 2002-02-11 0.26 ± 0.02 0.10 
EN00043 Adult Male 2002-03-20 0.18 ± 0.02 0.09 
EN00043 Adult Male 2002-05-28 0.17 ± 0.02 0.09 
EN00043 Adult Male 2002-06-26 0.15 ± 0.01 0.09 
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EN00043 Adult Male 2002-10-14 0.18 ± 0.01 0.10 
EN00043 Adult Male 2003-01-09 0.16 ± 0.01 0.10 
EN00043 Adult Male 2003-12-01 0.10 ± 0.01 0.15 
EN00043 Adult Male 2004-01-09 0.00 ± 0.00 0.08 
EN00043 Adult Male 2004-02-10 0.16 ± 0.02 0.17 
EN00043 Adult Male 2004-06-23 0.22 ± 0.04 0.16 
EN00043 Adult Male 2004-07-26 0.23 ± 0.04 0.19 
EN00044 Adult Male 2003-12-16 0.16 ± 0.02 0.17 
EN00044 Adult Male 2004-07-15 0.00 ± 0.00 0.12 
EN00044 Adult Male 2004-12-15 0.07 ± 0.02 0.10 
EN00045 Adult Male 2002-07-17 0.54 ± 0.03 0.11 
EN00046 Adult Male 2002-07-02 0.19 ± 0.02 0.10 
EN00046 Adult Male 2003-11-28 0.00 ± 0.00 0.08 
EN00046 Adult Male 2004-12-15 0.56 ± 0.04 0.15 
EN00047 Adult Male 2002-05-28 0.30 ± 0.02 0.10 
EN00047 Adult Male 2002-06-26 0.28 ± 0.02 0.10 
EN00047 Adult Male 2003-12-01 0.19 ± 0.02 0.16 
EN00047 Adult Male 2004-06-23 0.38 ± 0.04 0.18 
EN00047 Adult Male 2004-07-22 0.18 ± 0.03 0.14 
EN00047 Adult Male 2004-12-02 0.00 ± 0.00 0.07 
EN00048 Adult Male 2002-07-02 0.09 ± 0.01 0.08 
EN00048 Adult Male 2003-11-26 0.00 ± 0.00 0.08 
EN00049 Adult Male 2002-07-15 0.07 ± 0.01 0.09 
EN00050 Adult Male 2004-07-22 0.00 ± 0.00 0.11 
EN00051 Adult Male 2004-07-05 0.25 ± 0.06 0.25 
EN00051 Adult Male 2004-12-15 0.15 ± 0.03 0.13 
EN00052 Adult Male 2002-07-15 0.10 ± 0.01 0.08 
EN00052 Adult Male 2003-12-09 0.00 ± 0.00 0.07 
EN00053 Adult Male 2002-07-15 0.18 ± 0.02 0.10 
EN00053 Adult Male 2003-12-09 0.10 ± 0.02 0.17 
EN00054 Adult Male 2002-07-15 0.23 ± 0.02 0.10 
EN00054 Adult Male 2004-08-26 0.42 ± 0.08 0.35 
EN00057 Adult Male 2003-11-27 0.11 ± 0.02 0.15 
EN00059 Adult Male 2002-07-12 0.14 ± 0.01 0.09 
EN00059 Adult Male 2003-12-03 0.00 ± 0.00 0.08 
EN00059 Adult Male 2004-07-28 0.17 ± 0.04 0.19 
EN00061 Adult Female 2004-08-05 0.00 ± 0.00 0.06 
EN00064 Adult Male 2002-07-16 0.09 ± 0.01 0.09 
EN00064 Adult Male 2003-11-28 0.00 ± 0.00 0.08 
EN00065 Adult Male 2002-07-17 0.22 ± 0.02 0.10 
EN00065 Adult Male 2003-12-09 0.00 ± 0.00 0.08 
EN00065 Adult Male 2004-06-07 0.48 ± 0.05 0.20 
EN00065 Adult Male 2004-07-15 0.39 ± 0.04 0.16 
EN00068 Adult Male 2002-07-15 0.28 ± 0.02 0.10 
EN00068 Adult Male 2003-12-16 0.52 ± 0.03 0.17 
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EN00069 Adult Male 2002-07-17 0.15 ± 0.01 0.08 
EN00069 Adult Male 2004-07-30 0.10 ± 0.03 0.14 
EN00070 Adult Male 2002-07-16 0.32 ± 0.02 0.10 
EN00070 Adult Male 2004-08-04 0.09 ± 0.03 0.12 
EN00071 Adult Male 2003-12-04 0.00 ± 0.00 0.08 
EN00074 Adult Female 2004-05-22 0.16 ± 0.03 0.12 
EN00076 Teenager Male 2002-07-15 0.15 ± 0.01 0.10 
EN00076 Adult Male 2004-08-06 0.05 ± 0.03 0.13 
EN00078 Adult Female 2002-07-15 0.09 ± 0.01 0.09 
EN00080 Adult Male 2002-07-12 0.17 ± 0.01 0.09 
EN00080 Adult Male 2003-12-16 0.11 ± 0.02 0.17 
EN00081 Adult Male 2002-07-17 0.17 ± 0.02 0.10 
EN00081 Adult Male 2004-07-29 0.00 ± 0.00 0.11 
EN00082 Teenager Male 2002-07-12 0.21 ± 0.02 0.09 
EN00082 Adult Male 2003-12-12 0.14 ± 0.02 0.17 
EN00082 Adult Male 2004-09-17 0.00 ± 0.00 0.12 
EN00084 Adult Male 2002-02-19 0.20 ± 0.02 0.10 
EN00084 Adult Male 2002-03-15 0.23 ± 0.02 0.10 
EN00084 Adult Male 2002-05-27 0.12 ± 0.01 0.10 
EN00084 Adult Male 2002-06-27 0.19 ± 0.02 0.10 
EN00084 Adult Male 2002-12-02 0.22 ± 0.02 0.11 
EN00084 Adult Male 2003-01-09 0.17 ± 0.01 0.10 
EN00084 Adult Male 2003-12-01 0.15 ± 0.02 0.16 
EN00084 Adult Male 2004-01-13 0.13 ± 0.02 0.19 
EN00084 Adult Male 2004-02-11 0.10 ± 0.02 0.17 
EN00084 Adult Male 2004-06-24 0.17 ± 0.03 0.13 
EN00084 Adult Male 2004-07-23 0.15 ± 0.03 0.13 
EN00086 Adult Male 2004-07-20 0.00 ± 0.00 0.12 
EN00088 Adult Male 2002-07-12 0.07 ± 0.01 0.08 
EN00091 Adult Male 2003-12-04 0.00 ± 0.00 0.08 
EN00092 Adult Male 2002-07-15 0.14 ± 0.01 0.09 
EN00093 Adult Male 2004-07-05 0.20 ± 0.03 0.13 
EN00094 Adult Male 2002-07-15 0.22 ± 0.02 0.09 
EN00095 Adult Male 2002-07-02 0.18 ± 0.02 0.09 
EN00097 Adult Male 2002-07-12 0.09 ± 0.01 0.08 
EN00098 Adult Male 2002-07-17 0.13 ± 0.01 0.08 
EN00100 Adult Male 2003-01-20 0.35 ± 0.02 0.11 
EN00100 Adult Male 2003-12-15 0.30 ± 0.02 0.17 
EN00101 Adult Male 2003-12-03 0.00 ± 0.00 0.07 
EN00102 Adult Male 2003-01-20 0.07 ± 0.01 0.10 
EN00104 Adult Male 2003-01-20 0.07 ± 0.01 0.10 
EN00105 Adult Male 2003-01-20 0.18 ± 0.01 0.10 
EN00105 Adult Male 2003-12-15 0.13 ± 0.02 0.09 
EN00107 Adult Male 2003-01-22 0.16 ± 0.01 0.09 
EN00108 Adult Male 2003-12-12 0.20 ± 0.02 0.17 
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EN00109 Adult Male 2003-12-10 0.24 ± 0.02 0.17 
EN00110 Adult Male 2002-05-28 0.19 ± 0.02 0.09 
EN00110 Adult Male 2003-01-22 0.27 ± 0.02 0.10 
EN00111 Adult Male 2003-11-27 0.00 ± 0.00 0.08 
EN00114 Adult Male 2003-01-22 0.47 ± 0.02 0.11 
EN00114 Adult Male 2003-11-26 0.28 ± 0.02 0.16 
EN00116 Adult Male 2003-12-03 0.42 ± 0.02 0.16 
EN00116 Adult Male 2004-01-19 0.44 ± 0.03 0.18 
EN00117 Adult Male 2004-07-21 0.00 ± 0.00 0.11 
EN00119 Teenager Male 2002-07-10 0.07 ± 0.01 0.10 
EN00120 Adult Male 2003-12-15 0.00 ± 0.00 0.07 
EN00120 Adult Male 2004-06-02 0.07 ± 0.02 0.10 
EN00122 Adult Male 2004-07-15 0.62 ± 0.04 0.18 
EN00125 Adult Male 2004-12-01 0.45 ± 0.03 0.14 
EN00126 Adult Male 2003-01-28 0.81 ± 0.04 0.12 
EN00127 Adult Male 2003-01-22 0.59 ± 0.03 0.11 
EN00128 Adult Male 2003-01-24 0.08 ± 0.01 0.09 
EN00128 Adult Male 2003-12-03 0.21 ± 0.02 0.28 
EN00130 Adult Male 2003-01-28 0.13 ± 0.01 0.07 
EN00130 Adult Male 2003-12-03 0.00 ± 0.00 0.07 
EN00131 Adult Male 2003-01-22 0.09 ± 0.01 0.10 
EN00132 Adult Male 2003-11-28 0.00 ± 0.00 0.08 
EN00132 Adult Male 2004-09-02 0.00 ± 0.00 0.11 
EN00133 Adult Male 2003-12-03 0.00 ± 0.00 0.07 
EN00135 Adult Male 2003-12-03 0.03 ± 0.01 0.08 
EN00136 Adult Male 2003-01-24 0.24 ± 0.02 0.10 
EN00139 Adult Male 2002-11-27 0.45 ± 0.02 0.11 
EN00139 Adult Male 2003-01-28 0.29 ± 0.02 0.11 
EN00140 Adult Male 2003-01-28 0.21 ± 0.02 0.11 
EN00142 Adult Male 2003-01-28 0.30 ± 0.02 0.11 
EN00142 Adult Male 2004-06-14 0.46 ± 0.04 0.17 
EN00143 Adult Male 2003-01-28 0.21 ± 0.02 0.10 
EN00146 Adult Male 2004-01-16 0.12 ± 0.02 0.18 
EN00150 Adult Male 2002-07-12 0.17 ± 0.01 0.09 
EN00150 Adult Male 2004-06-14 0.75 ± 0.04 0.17 
EN00150 Adult Male 2004-07-08 0.57 ± 0.05 0.20 
EN00151 Adult Male 2002-02-22 0.40 ± 0.02 0.10 
EN00151 Adult Male 2002-07-15 0.93 ± 0.05 0.11 
EN00151 Adult Male 2002-10-08 0.84 ± 0.04 0.12 
EN00151 Adult Male 2003-01-15 0.62 ± 0.03 0.11 
EN00151 Adult Male 2003-12-17 0.33 ± 0.02 0.17 
EN00151 Adult Male 2004-07-27 0.00 ± 0.00 0.12 
EN00156 Adult Male 2004-07-26 0.00 ± 0.00 0.11 
EN00159 Adult Male 2003-12-02 0.19 ± 0.02 0.16 
EN00161 Adult Male 2003-11-26 0.00 ± 0.00 0.07 
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EN00163 Adult Male 2004-02-04 0.00 ± 0.00 0.08 
EN00163 Adult Male 2004-06-07 0.20 ± 0.03 0.15 
EN00165 Adult Male 2004-07-05 0.25 ± 0.04 0.17 
EN00166 Teenager Male 2003-12-02 0.00 ± 0.00 0.07 
EN00166 Adult Male 2004-09-29 0.00 ± 0.00 0.06 
EN00168 Adult Male 2004-06-25 0.04 ± 0.02 0.08 
EN00171 Adult Male 2004-07-21 0.00 ± 0.00 0.11 
EN00172 Adult Male 2002-07-12 0.26 ± 0.02 0.10 
EN00173 Adult Male 2003-11-27 0.09 ± 0.02 0.17 
EN00178 Adult Male 2004-08-05 0.00 ± 0.00 0.12 
EN00180 Teenager Male 2004-03-22 0.00 ± 0.00 0.06 
EN00181 Teenager Male 2002-07-10 0.08 ± 0.01 0.09 
EN00181 Teenager Male 2003-07-23 0.00 ± 0.00 0.11 
EN00182 Teenager Male 2003-02-04 0.00 ± 0.00 0.07 
EN00182 Teenager Male 2003-11-29 0.00 ± 0.00 0.07 
EN00185 Adult Male 2003-12-03 0.66 ± 0.03 0.17 
EN00185 Adult Male 2004-06-08 1.42 ± 0.06 0.20 
EN00185 Adult Male 2004-07-08 1.18 ± 0.06 0.24 
EN00193 Adult Female 2003-12-04 0.07 ± 0.01 0.12 
EN00193 Adult Female 2004-03-24 0.12 ± 0.02 0.10 
EN00196 Adult Female 2003-12-16 0.00 ± 0.00 0.07 
EN00197 Adult Female 2003-12-10 0.00 ± 0.00 0.07 
EN00200 Adult Male 2003-07-24 0.00 ± 0.00 0.11 
EN00201 Adult Female 2004-05-24 0.09 ± 0.03 0.12 
EN00202 Adult Female 2003-12-10 0.00 ± 0.00 0.07 
EN00204 Adult Female 2004-06-16 0.18 ± 0.04 0.18 
EN00204 Adult Female 2004-06-16 0.18 ± 0.04 0.19 
EN00207 Adult Female 2003-11-25 0.00 ± 0.00 0.08 
EN00208 Adult Female 2004-08-02 0.13 ± 0.03 0.13 
EN00216 Teenager Female 2003-02-03 0.00 ± 0.00 0.07 
EN00217 Pre-Teen Female 2003-02-05 0.15 ± 0.01 0.08 
EN00220 Adult Female 2003-11-24 0.00 ± 0.00 0.07 
EN00221 Adult Female 2004-07-20 0.00 ± 0.00 0.12 
EN00223 Teenager Male 2004-07-21 0.16 ± 0.03 0.11 
EN00226 Adult Male 2003-12-16 0.00 ± 0.00 0.07 
EN00226 Adult Male 2004-07-15 0.00 ± 0.00 0.06 
EN00228 Adult Male 2004-01-15 0.18 ± 0.02 0.18 
EN00228 Adult Male 2004-02-10 0.21 ± 0.02 0.16 
EN00228 Adult Male 2004-06-23 0.24 ± 0.03 0.15 
EN00228 Adult Male 2004-07-21 0.20 ± 0.03 0.14 
EN00228 Adult Male 2004-10-01 0.23 ± 0.04 0.19 
EN00230 Adult Male 2004-01-13 0.12 ± 0.02 0.17 
EN00230 Adult Male 2004-02-10 0.00 ± 0.00 0.08 
EN00230 Adult Male 2004-06-23 0.30 ± 0.04 0.17 
EN00230 Adult Male 2004-07-22 0.20 ± 0.03 0.13 
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EN00230 Adult Male 2004-10-01 0.18 ± 0.03 0.12 
EN00231 Pre-Teen Female 2003-02-12 0.00 ± 0.00 0.07 
EN00231 Pre-Teen Female 2003-11-22 0.00 ± 0.00 0.07 
EN00232 Pre-Teen Female 2003-11-22 0.00 ± 0.00 0.07 
EN00233 Pre-Teen Female 2003-02-04 0.00 ± 0.00 0.07 
EN00233 Teenager Female 2003-11-22 0.00 ± 0.00 0.07 
EN00233 Teenager Female 2004-08-13 0.00 ± 0.00 0.11 
EN00234 Pre-Teen Female 2004-03-30 0.04 ± 0.02 0.09 
EN00237 Adult Female 2003-12-02 0.08 ± 0.01 0.11 
EN00240 Adult Female 2003-11-25 0.00 ± 0.00 0.07 
EN00241 Adult Female 2003-11-19 0.00 ± 0.00 0.07 
EN00242 Adult Female 2003-11-19 0.00 ± 0.00 0.07 
EN00244 Adult Male 2004-06-08 0.60 ± 0.04 0.17 
EN00244 Adult Male 2004-07-14 0.53 ± 0.05 0.21 
EN00249 Adult Female 2003-12-02 0.17 ± 0.02 0.14 
EN00252 Adult Female 2003-01-15 0.34 ± 0.02 0.11 
EN00253 Adult Female 2004-06-16 0.05 ± 0.02 0.11 
EN00260 Adult Female 2003-07-29 0.00 ± 0.00 0.10 
EN00262 Adult Female 2003-11-25 0.00 ± 0.00 0.08 
EN00265 Adult Female 2004-08-02 0.00 ± 0.00 0.06 
EN00267 Adult Female 2003-12-10 0.10 ± 0.02 0.16 
EN00268 Adult Female 2004-06-16 0.10 ± 0.02 0.11 
EN00274 Adult Female 2004-06-14 0.83 ± 0.04 0.17 
EN00274 Adult Female 2004-07-08 0.67 ± 0.04 0.18 
EN00280 Adult Female 2004-05-22 0.15 ± 0.03 0.12 
EN00287 Adult Female 2002-07-01 0.05 ± 0.01 0.08 
EN00288 Adult Female 2004-08-02 0.01 ± 0.02 0.09 
EN00290 Adult Female 2004-07-20 0.00 ± 0.00 0.11 
EN00291 Adult Female 2004-10-20 0.00 ± 0.00 0.11 
EN00293 Adult Female 2004-05-22 0.16 ± 0.03 0.11 
EN00296 Adult Female 2004-05-21 0.28 ± 0.04 0.18 
EN00298 Adult Female 2004-05-21 0.07 ± 0.03 0.12 
EN00299 Adult Female 2003-12-09 0.00 ± 0.00 0.07 
EN00302 Adult Female 2003-12-17 0.08 ± 0.01 0.12 
EN00304 Teenager Female 2004-07-30 0.00 ± 0.00 0.06 
EN00305 Adult Female 2004-06-07 0.33 ± 0.03 0.14 
EN00306 Adult Female 2004-05-22 0.23 ± 0.03 0.15 
EN00307 Adult Female 2003-11-24 0.00 ± 0.00 0.07 
EN00315 Adult Female 2003-12-10 0.00 ± 0.00 0.07 
EN00316 Adult Female 2003-11-24 0.00 ± 0.00 2.02 
EN00317 Adult Female 2003-12-10 0.00 ± 0.00 0.07 
EN00317 Adult Female 2004-07-06 0.13 ± 0.03 0.12 
EN00321 Adult Male 2002-06-13 0.10 ± 0.01 0.08 
EN00321 Adult Male 2003-12-10 0.06 ± 0.02 0.16 
EN00328 Adult Male 2004-08-06 0.00 ± 0.00 0.12 
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EN00331 Adult Female 2003-11-24 0.11 ± 0.02 0.16 
EN00337 Adult Female 2003-11-24 0.00 ± 0.00 0.07 
EN00339 Adult Female 2004-06-07 0.07 ± 0.02 0.08 
EN00345 Adult Female 2003-12-02 0.00 ± 0.00 0.07 
EN00347 Adult Female 2004-05-22 0.04 ± 0.02 0.10 
EN00348 Adult Female 2003-12-10 0.05 ± 0.01 0.14 
EN00353 Adult Male 2004-12-09 0.05 ± 0.02 0.09 
EN00354 Adult Male 2003-12-08 0.08 ± 0.01 0.13 
EN00354 Adult Male 2004-07-28 0.15 ± 0.02 0.11 
EN00355 Adult Male 2003-12-08 0.05 ± 0.01 0.12 
EN00362 Adult Female 2003-12-04 0.00 ± 0.00 0.08 
EN00362 Adult Female 2004-07-06 0.19 ± 0.03 0.12 
EN00364 Adult Male 2003-12-02 0.10 ± 0.01 0.16 
EN00364 Adult Male 2004-09-17 0.00 ± 0.00 0.12 
EN00375 Adult Male 2002-03-20 0.14 ± 0.01 0.09 
EN00375 Adult Male 2002-05-28 0.26 ± 0.02 0.10 
EN00375 Adult Male 2002-06-26 0.18 ± 0.02 0.09 
EN00375 Adult Male 2002-11-27 0.16 ± 0.02 0.10 
EN00375 Adult Male 2004-01-13 0.10 ± 0.02 0.18 
EN00375 Adult Male 2004-02-10 0.09 ± 0.02 0.17 
EN00375 Adult Male 2004-06-24 0.12 ± 0.02 0.11 
EN00375 Adult Male 2004-07-28 0.10 ± 0.03 0.13 
EN00376 Adult Male 2004-07-21 0.49 ± 0.04 0.17 
EN00378 Adult Male 2004-12-15 0.11 ± 0.03 0.15 
EN00379 Adult Male 2003-12-02 0.11 ± 0.01 0.14 
EN00379 Adult Male 2004-07-15 0.09 ± 0.03 0.13 
EN00380 Adult Male 2004-07-14 0.15 ± 0.03 0.13 
EN00382 Adult Male 2003-11-28 0.00 ± 0.00 0.07 
EN00383 Adult Male 2003-11-27 0.00 ± 0.00 1.96 
EN00383 Adult Male 2004-12-10 0.00 ± 0.00 0.06 
EN00387 Adult Female 2004-05-21 0.46 ± 0.04 0.15 
EN00388 Teenager Male 2004-09-29 0.43 ± 0.04 0.17 
EN00394 Adult Male 2003-11-19 0.00 ± 0.00 0.07 
EN00394 Adult Male 2004-05-31 0.04 ± 0.02 0.09 
EN00398 Adult Male 2002-07-11 0.18 ± 0.02 0.09 
EN00399 Adult Female 2003-07-24 0.00 ± 0.00 0.10 
EN00400 Adult Female 2003-11-25 0.00 ± 0.00 0.07 
EN00400 Adult Female 2004-06-14 0.08 ± 0.02 0.11 
EN00403 Adult Male 2004-03-19 0.26 ± 0.04 0.19 
EN00403 Adult Male 2004-08-05 0.21 ± 0.03 0.15 
EN00405 Adult Female 2003-12-15 0.08 ± 0.01 0.15 
EN00412 Adult Male 2004-07-19 0.46 ± 0.04 0.19 
EN00412 Adult Male 2004-07-29 0.38 ± 0.04 0.17 
EN00415 Teenager Male 2004-08-05 0.04 ± 0.02 0.08 
EN00420 Adult Male 2004-01-19 0.24 ± 0.02 0.17 
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EN00421 Adult Female 2002-02-13 0.07 ± 0.01 0.09 
EN00422 Adult Male 2002-02-19 0.00 ± 0.00 0.06 
EN00422 Adult Male 2003-11-27 0.00 ± 0.00 0.07 
EN00423 Teenager Male 2002-02-19 0.00 ± 0.00 0.06 
EN00424 Adult Male 2002-02-20 0.12 ± 0.01 0.09 
EN00425 Adult Male 2002-02-20 0.08 ± 0.01 0.08 
EN00426 Adult Male 2002-02-27 0.10 ± 0.01 0.07 
EN00426 Adult Male 2003-12-16 0.08 ± 0.01 0.16 
EN00427 Adult Female 2002-02-27 0.06 ± 0.01 0.08 
EN00428 Adult Male 2002-02-27 0.10 ± 0.01 0.09 
EN00428 Adult Male 2003-12-02 0.08 ± 0.01 0.09 
EN00429 Adult Male 2002-02-27 0.00 ± 0.00 0.06 
EN00430 Adult Female 2002-03-04 0.35 ± 0.02 0.10 
EN00430 Adult Female 2003-11-24 0.00 ± 0.00 0.08 
EN00431 Adult Female 2002-03-04 0.06 ± 0.01 0.08 
EN00432 Teenager Female 2002-03-04 0.00 ± 0.00 0.06 
EN00432 Adult Female 2004-07-30 0.00 ± 0.00 0.06 
EN00433 Adult Female 2002-03-04 0.00 ± 0.00 0.06 
EN00434 Adult Male 2002-03-05 0.11 ± 0.01 0.09 
EN00434 Adult Male 2003-12-02 0.00 ± 0.00 0.08 
EN00434 Adult Male 2004-06-24 0.12 ± 0.03 0.13 
EN00434 Adult Male 2004-09-13 0.36 ± 0.07 0.32 
EN00435 Adult Male 2002-03-05 0.24 ± 0.02 0.11 
EN00435 Adult Male 2004-01-23 0.07 ± 0.02 0.18 
EN00435 Adult Male 2004-07-28 0.00 ± 0.00 0.12 
EN00436 Adult Female 2002-03-06 0.19 ± 0.02 0.07 
EN00437 Adult Male 2004-07-29 0.24 ± 0.03 0.12 
EN00438 Adult Female 2002-04-02 0.00 ± 0.00 0.06 
EN00439 Adult Female 2002-04-02 0.00 ± 0.00 0.06 
EN00440 Adult Female 2002-04-03 0.14 ± 0.01 0.10 
EN00441 Adult Male 2002-05-23 0.11 ± 0.01 0.08 
EN00442 Adult Female 2002-06-05 0.00 ± 0.00 0.06 
EN00443 Adult Female 2002-06-05 0.06 ± 0.01 0.09 
EN00444 Adult Male 2002-06-05 0.00 ± 0.00 0.06 
EN00445 Adult Female 2002-06-06 0.09 ± 0.01 0.07 
EN00446 Adult Male 2002-06-06 0.04 ± 0.01 0.09 
EN00447 Adult Male 2002-06-06 0.00 ± 0.00 0.06 
EN00448 Teenager Male 2002-06-07 0.00 ± 0.00 0.06 
EN00449 Teenager Female 2002-06-07 0.22 ± 0.02 0.10 
EN00450 Teenager Male 2002-06-07 0.00 ± 0.00 0.06 
EN00450 Adult Male 2004-07-14 0.08 ± 0.02 0.11 
EN00451 Teenager Female 2002-06-07 0.13 ± 0.01 0.08 
EN00452 Teenager Female 2002-06-07 0.16 ± 0.01 0.08 
EN00453 Teenager Female 2002-06-07 0.05 ± 0.01 0.08 
EN00454 Teenager Male 2002-06-11 0.26 ± 0.02 0.10 
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EN00454 Adult Male 2004-06-08 0.13 ± 0.03 0.14 
EN00455 Teenager Female 2002-06-19 0.00 ± 0.00 0.06 
EN00456 Adult Male 2002-06-19 0.10 ± 0.01 0.07 
EN00457 Adult Male 2002-06-25 0.45 ± 0.03 0.10 
EN00457 Adult Male 2003-12-02 0.25 ± 0.02 0.15 
EN00457 Adult Male 2004-07-15 0.18 ± 0.03 0.12 
EN00458 Adult Male 2002-06-27 0.06 ± 0.01 0.09 
EN00459 Adult Female 2002-06-27 0.00 ± 0.00 0.06 
EN00460 Adult Male 2002-07-01 0.00 ± 0.00 0.06 
EN00462 Adult Male 2002-07-01 0.30 ± 0.02 0.10 
EN00463 Pre-Teen Female 2002-07-10 0.08 ± 0.01 0.10 
EN00463 Teenager Male 2003-02-04 0.00 ± 0.00 0.07 
EN00463 Teenager Male 2003-11-29 0.00 ± 0.00 0.07 
EN00464 Teenager Male 2002-07-10 0.35 ± 0.02 0.10 
EN00464 Teenager Male 2003-02-10 0.15 ± 0.01 0.09 
EN00465 Pre-Teen Male 2002-07-10 0.52 ± 0.03 0.10 
EN00465 Pre-Teen Male 2003-02-12 0.29 ± 0.02 0.10 
EN00465 Teenager Male 2004-03-22 0.42 ± 0.04 0.19 
EN00466 Adult Female 2002-10-08 0.00 ± 0.00 0.07 
EN00467 Adult Male 2002-10-08 0.00 ± 0.00 0.07 
EN00468 Adult Male 2002-10-08 0.00 ± 0.00 0.08 
EN00469 Adult Female 2002-10-08 0.00 ± 0.00 0.07 
EN00470 Adult Male 2002-11-12 0.05 ± 0.01 0.07 
EN00471 Adult Female 2002-11-12 0.00 ± 0.00 0.07 
EN00472 Adult Male 2002-11-12 0.00 ± 0.00 0.07 
EN00473 Adult Female 2002-11-12 0.00 ± 0.00 0.07 
EN00474 Teenager Female 2002-11-13 0.00 ± 0.00 0.07 
EN00474 Adult Female 2003-12-10 0.00 ± 0.00 0.07 
EN00475 Adult Male 2002-11-13 0.00 ± 0.00 0.07 
EN00476 Adult Female 2002-11-13 0.00 ± 0.00 0.07 
EN00477 Adult Female 2002-11-13 0.09 ± 0.01 0.09 
EN00479 Teenager Female 2002-11-14 0.18 ± 0.01 0.08 
EN00479 Teenager Female 2003-12-16 0.06 ± 0.01 0.15 
EN00480 Adult Female 2002-11-14 0.07 ± 0.01 0.11 
EN00482 Adult Male 2004-07-05 0.26 ± 0.03 0.13 
EN00483 Adult Male 2003-01-02 0.00 ± 0.00 0.07 
EN00485 Adult Female 2003-01-13 0.09 ± 0.01 0.08 
EN00486 Adult Male 2003-01-13 0.09 ± 0.01 0.08 
EN00486 Adult Male 2004-07-08 0.55 ± 0.05 0.22 
EN00487 Adult Female 2003-01-13 0.12 ± 0.01 0.10 
EN00487 Adult Female 2004-09-08 0.00 ± 0.00 3.35 
EN00488 Adult Male 2003-01-13 0.20 ± 0.02 0.10 
EN00488 Adult Male 2004-09-08 0.23 ± 0.05 0.21 
EN00489 Adult Female 2003-01-14 0.00 ± 0.00 0.07 
EN00490 Adult Female 2003-01-14 0.00 ± 0.00 0.07 
 A-17 
Table 1. Continued. 
 
137Cs (kBq) 




Date Value MDA 
 
EN00491 Adult Female 2003-01-15 0.08 ± 0.01 0.10 
EN00491 Adult Female 2003-11-25 0.00 ± 0.00 0.08 
EN00492 Adult Male 2003-01-20 0.12 ± 0.01 0.09 
EN00493 Teenager Male 2003-01-31 0.00 ± 0.00 0.07 
EN00494 Teenager Male 2003-01-31 0.10 ± 0.01 0.07 
EN00495 Teenager Male 2003-01-31 0.00 ± 0.00 0.07 
EN00496 Teenager Female 2003-01-31 0.04 ± 0.01 0.09 
EN00497 Teenager Female 2003-01-31 0.00 ± 0.00 0.07 
EN00498 Teenager Female 2003-01-31 0.06 ± 0.01 0.07 
EN00499 Teenager Female 2003-01-31 0.00 ± 0.00 0.07 
EN00500 Teenager Male 2003-01-31 0.04 ± 0.01 0.09 
EN00501 Teenager Male 2003-01-31 0.00 ± 0.00 0.07 
EN00502 Teenager Male 2003-01-31 0.00 ± 0.00 0.07 
EN00503 Teenager Male 2003-02-03 0.13 ± 0.01 0.08 
EN00503 Teenager Male 2004-07-05 0.03 ± 0.02 0.07 
EN00504 Teenager Male 2003-02-03 0.14 ± 0.01 0.09 
EN00505 Teenager Male 2003-02-03 0.09 ± 0.01 0.10 
EN00505 Teenager Male 2004-07-26 0.00 ± 0.00 0.11 
EN00506 Teenager Female 2003-02-04 0.11 ± 0.01 0.08 
EN00506 Teenager Female 2003-11-22 0.00 ± 0.00 0.07 
EN00507 Pre-Teen Female 2003-02-04 0.05 ± 0.01 0.08 
EN00507 Teenager Female 2003-11-22 0.00 ± 0.00 0.07 
EN00508 Teenager Male 2003-02-04 0.10 ± 0.01 0.09 
EN00509 Teenager Female 2003-02-04 0.00 ± 0.00 0.07 
EN00509 Teenager Female 2003-11-22 0.00 ± 0.00 0.07 
EN00510 Pre-Teen Female 2003-02-04 0.00 ± 0.00 0.07 
EN00511 Pre-Teen Male 2003-02-04 0.12 ± 0.01 0.10 
EN00511 Teenager Male 2003-11-29 0.00 ± 0.00 0.08 
EN00512 Teenager Male 2003-02-04 0.15 ± 0.01 0.09 
EN00512 Teenager Male 2003-11-29 0.00 ± 0.00 0.08 
EN00513 Teenager Male 2003-02-05 0.12 ± 0.01 0.09 
EN00513 Teenager Male 2003-11-29 0.06 ± 0.01 0.16 
EN00514 Teenager Male 2003-02-05 0.10 ± 0.01 0.08 
EN00515 Teenager Female 2003-02-05 0.08 ± 0.01 0.07 
EN00516 Teenager Female 2003-02-05 0.00 ± 0.00 0.07 
EN00517 Adult Male 2003-02-10 0.15 ± 0.01 0.08 
EN00517 Adult Male 2004-08-06 0.13 ± 0.03 0.15 
EN00518 Teenager Male 2003-02-10 0.13 ± 0.01 0.07 
EN00518 Teenager Male 2003-11-29 0.00 ± 0.00 0.08 
EN00519 Teenager Male 2003-02-10 0.09 ± 0.01 0.08 
EN00519 Teenager Male 2003-11-28 0.00 ± 0.00 0.07 
EN00520 Teenager Male 2003-02-10 0.04 ± 0.01 0.10 
EN00521 Teenager Male 2003-02-10 0.19 ± 0.01 0.08 
EN00522 Teenager Male 2003-02-10 0.00 ± 0.00 0.07 
EN00523 Teenager Female 2003-02-10 0.00 ± 0.00 0.07 
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EN00523 Teenager Female 2003-11-22 0.00 ± 0.00 0.07 
EN00524 Teenager Male 2003-02-10 0.14 ± 0.01 0.09 
EN00525 Pre-Teen Female 2003-02-12 0.00 ± 0.00 0.07 
EN00525 Pre-Teen Female 2004-03-25 0.00 ± 0.00 0.06 
EN00526 Pre-Teen Male 2003-02-12 0.11 ± 0.01 0.08 
EN00526 Teenager Male 2004-03-25 0.13 ± 0.03 0.15 
EN00527 Teenager Male 2003-02-12 0.11 ± 0.01 0.08 
EN00528 Pre-Teen Male 2003-02-12 0.00 ± 0.00 0.07 
EN00529 Pre-Teen Male 2003-02-12 0.07 ± 0.01 0.07 
EN00530 Teenager Male 2003-02-12 0.17 ± 0.01 0.09 
EN00530 Teenager Male 2004-03-25 0.27 ± 0.04 0.18 
EN00531 Pre-Teen Male 2003-02-12 0.10 ± 0.01 0.09 
EN00532 Teenager Male 2003-02-12 0.14 ± 0.01 0.07 
EN00533 Adult Male 2002-01-10 0.00 ± 0.00 0.06 
EN00533 Adult Male 2003-12-15 0.00 ± 0.00 0.07 
EN00534 Adult Male 2002-03-28 0.00 ± 0.00 0.06 
EN00536 Pre-Teen Male 2003-11-19 0.00 ± 0.00 0.07 
EN00536 Pre-Teen Male 2004-04-06 0.07 ± 0.02 0.10 
EN00537 Adult Male 2003-11-19 0.00 ± 0.00 0.07 
EN00538 Adult Female 2003-11-19 0.05 ± 0.01 0.13 
EN00539 Adult Female 2003-11-19 0.00 ± 0.00 0.07 
EN00540 Adult Male 2003-11-19 0.06 ± 0.01 0.15 
EN00541 Adult Male 2003-11-27 0.00 ± 0.00 0.08 
EN00542 Teenager Male 2003-12-02 0.09 ± 0.02 0.12 
EN00543 Teenager Male 2003-12-08 0.00 ± 0.00 0.07 
EN00543 Teenager Male 2004-08-06 0.05 ± 0.02 0.09 
EN00544 Teenager Male 2003-12-09 0.00 ± 0.00 0.07 
EN00545 Adult Male 2003-12-09 0.09 ± 0.01 0.16 
EN00546 Adult Female 2003-12-09 0.00 ± 0.00 0.07 
EN00547 Adult Female 2003-12-10 0.00 ± 0.00 0.07 
EN00548 Teenager Female 2003-12-15 0.09 ± 0.01 0.14 
EN00549 Adult Female 2003-12-15 0.00 ± 0.00 0.07 
EN00550 Adult Female 2003-12-16 0.00 ± 0.00 0.07 
EN00551 Adult Female 2003-12-16 0.00 ± 0.00 0.07 
EN00553 Adult Male 2004-01-26 0.06 ± 0.01 0.14 
EN00554 Adult Female 2004-01-26 0.00 ± 0.00 0.07 
EN00555 Adult Male 2004-02-04 0.00 ± 0.00 0.07 
EN00556 Adult Male 2004-03-17 0.00 ± 0.00 0.06 
EN00556 Adult Male 2004-07-15 0.00 ± 0.00 0.11 
EN00557 Adult Female 2004-03-19 0.37 ± 0.05 0.20 
EN00558 Teenager Female 2004-03-22 0.00 ± 0.00 0.06 
EN00559 Teenager Male 2004-03-22 0.00 ± 0.00 0.06 
EN00560 Pre-Teen Female 2004-03-22 0.11 ± 0.02 0.10 
EN00561 Pre-Teen Male 2004-03-22 0.00 ± 0.00 0.06 
EN00562 Adult Male 2004-03-24 0.24 ± 0.03 0.13 
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EN00563 Adult Female 2004-03-24 0.08 ± 0.02 0.09 
EN00564 Adult Male 2004-03-24 0.00 ± 0.00 0.06 
EN00565 Adult Female 2004-03-24 0.07 ± 0.02 0.07 
EN00566 Adult Unknown 2004-03-24 0.11 ± 0.03 0.13 
EN00567 Adult Male 2004-03-24 0.00 ± 0.00 0.07 
EN00568 Adult Male 2004-03-24 0.44 ± 0.04 0.15 
EN00568 Adult Male 2004-03-24 0.52 ± 0.05 0.20 
EN00569 Teenager Male 2004-03-25 0.07 ± 0.03 0.12 
EN00570 Pre-Teen Male 2004-03-25 0.10 ± 0.02 0.11 
EN00571 Teenager Male 2004-03-25 0.00 ± 0.00 0.06 
EN00572 Pre-Teen Male 2004-03-25 0.09 ± 0.02 0.10 
EN00573 Teenager Male 2004-03-25 0.00 ± 0.00 0.06 
EN00573 Teenager Male 2004-06-08 0.67 ± 0.04 0.18 
EN00574 Pre-Teen Female 2004-03-25 0.00 ± 0.00 0.06 
EN00575 Pre-Teen Female 2004-03-25 0.10 ± 0.02 0.10 
EN00576 Pre-Teen Female 2004-03-26 0.00 ± 0.00 0.06 
EN00577 Pre-Teen Male 2004-03-26 0.00 ± 0.00 0.06 
EN00578 Pre-Teen Male 2004-03-26 0.19 ± 0.04 0.16 
EN00579 Pre-Teen Male 2004-03-29 0.00 ± 0.00 0.06 
EN00580 Pre-Teen Male 2004-03-29 0.00 ± 0.00 0.06 
EN00581 Pre-Teen Male 2004-03-29 0.06 ± 0.02 0.09 
EN00582 Pre-Teen Female 2004-03-29 0.00 ± 0.00 0.06 
EN00583 Pre-Teen Female 2004-03-29 0.00 ± 0.00 0.06 
EN00584 Pre-Teen Female 2004-03-29 0.00 ± 0.00 0.06 
EN00585 Teenager Female 2004-03-29 0.06 ± 0.02 0.10 
EN00586 Pre-Teen Female 2004-03-29 0.00 ± 0.00 0.06 
EN00587 Pre-Teen Male 2004-03-29 0.00 ± 0.00 0.06 
EN00587 Pre-Teen Male 2004-06-07 1.62 ± 0.07 0.22 
EN00587 Pre-Teen Male 2004-07-12 1.11 ± 0.05 0.18 
EN00588 Pre-Teen Male 2004-03-29 0.04 ± 0.03 0.12 
EN00589 Pre-Teen Male 2004-03-29 0.05 ± 0.02 0.08 
EN00590 Teenager Female 2004-03-30 0.11 ± 0.02 0.10 
EN00591 Teenager Female 2004-03-30 0.00 ± 0.00 0.06 
EN00592 Teenager Female 2004-03-30 0.05 ± 0.02 0.09 
EN00593 Pre-Teen Female 2004-03-30 0.00 ± 0.00 0.06 
EN00594 Pre-Teen Male 2004-03-30 0.00 ± 0.00 0.06 
EN00595 Pre-Teen Male 2004-03-30 0.00 ± 0.00 0.06 
EN00596 Teenager Male 2004-03-30 0.00 ± 0.00 0.06 
EN00597 Adult Female 2004-03-30 0.00 ± 0.00 0.06 
EN00598 Pre-Teen Male 2004-03-30 0.05 ± 0.02 0.09 
EN00599 Pre-Teen Male 2004-03-30 0.08 ± 0.03 0.12 
EN00600 Pre-Teen Female 2004-03-30 0.00 ± 0.00 0.06 
EN00601 Pre-Teen Female 2004-03-30 0.00 ± 0.00 0.06 
EN00602 Pre-Teen Male 2004-03-30 0.00 ± 0.00 0.06 
EN00603 Pre-Teen Male 2004-03-31 0.14 ± 0.03 0.13 
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EN00604 Pre-Teen Male 2004-03-31 0.03 ± 0.02 0.08 
EN00604 Pre-Teen Male 2004-06-07 0.99 ± 0.05 0.18 
EN00604 Pre-Teen Male 2004-07-08 0.66 ± 0.04 0.16 
EN00605 Pre-Teen Male 2004-03-31 0.05 ± 0.02 0.07 
EN00607 Pre-Teen Female 2004-03-31 0.04 ± 0.02 0.10 
EN00608 Pre-Teen Female 2004-03-31 0.00 ± 0.00 0.06 
EN00609 Pre-Teen Female 2004-03-31 0.06 ± 0.02 0.09 
EN00610 Pre-Teen Female 2004-03-31 0.00 ± 0.00 0.06 
EN00611 Pre-Teen Female 2004-03-31 0.00 ± 0.00 0.06 
EN00612 Pre-Teen Male 2004-03-31 0.05 ± 0.02 0.10 
EN00613 Pre-Teen Male 2004-03-31 0.00 ± 0.00 0.06 
EN00614 Pre-Teen Male 2004-03-31 0.06 ± 0.02 0.08 
EN00615 Pre-Teen Male 2004-04-05 0.28 ± 0.03 0.14 
EN00616 Pre-Teen Male 2004-04-05 0.06 ± 0.02 0.10 
EN00616 Pre-Teen Male 2004-07-08 0.20 ± 0.04 0.17 
EN00617 Pre-Teen Male 2004-04-05 0.00 ± 0.00 0.06 
EN00618 Pre-Teen Male 2004-04-05 0.04 ± 0.02 0.08 
EN00618 Pre-Teen Male 2004-07-08 0.12 ± 0.02 0.11 
EN00619 Pre-Teen Male 2004-04-05 0.25 ± 0.03 0.15 
EN00620 Pre-Teen Female 2004-04-05 0.00 ± 0.00 0.06 
EN00621 Pre-Teen Male 2004-04-05 0.00 ± 0.00 0.06 
EN00622 Pre-Teen Male 2004-04-05 0.04 ± 0.02 0.08 
EN00623 Pre-Teen Female 2004-04-05 0.00 ± 0.02 0.06 
EN00624 Pre-Teen Female 2004-04-05 0.04 ± 0.02 0.08 
EN00625 Pre-Teen Male 2004-04-05 0.00 ± 0.00 0.06 
EN00626 Pre-Teen Male 2004-04-05 0.00 ± 0.00 0.06 
EN00626 Pre-Teen Male 2004-06-07 0.68 ± 0.04 0.16 
EN00626 Pre-Teen Male 2004-07-08 0.51 ± 0.05 0.21 
EN00627 Pre-Teen Female 2004-04-05 0.21 ± 0.03 0.15 
EN00628 Pre-Teen Female 2004-04-05 0.00 ± 0.00 0.06 
EN00629 Pre-Teen Female 2004-04-06 0.10 ± 0.03 0.13 
EN00630 Pre-Teen Female 2004-04-06 0.04 ± 0.02 0.09 
EN00631 Pre-Teen Female 2004-04-06 0.00 ± 0.00 0.06 
EN00632 Pre-Teen Female 2004-04-06 0.00 ± 0.00 0.06 
EN00633 Pre-Teen Female 2004-04-06 0.06 ± 0.02 0.09 
EN00634 Pre-Teen Male 2004-04-06 0.15 ± 0.04 0.16 
EN00635 Pre-Teen Male 2004-04-06 0.00 ± 0.00 0.06 
EN00636 Pre-Teen Male 2004-04-06 0.05 ± 0.02 0.09 
EN00637 Pre-Teen Female 2004-04-06 0.00 ± 0.00 0.06 
EN00638 Pre-Teen Female 2004-04-06 0.00 ± 0.00 0.06 
EN00639 Pre-Teen Female 2004-04-06 0.00 ± 0.00 0.06 
EN00640 Pre-Teen Female 2004-04-06 0.00 ± 0.00 0.06 
EN00641 Pre-Teen Female 2004-04-06 0.00 ± 0.00 0.06 
EN00642 Pre-Teen Female 2004-04-07 0.03 ± 0.02 0.08 
EN00643 Pre-Teen Female 2004-04-07 0.06 ± 0.02 0.09 
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EN00644 Pre-Teen Female 2004-04-07 0.00 ± 0.00 0.06 
EN00645 Pre-Teen Male 2004-04-07 0.05 ± 0.02 0.07 
EN00646 Pre-Teen Male 2004-04-07 0.03 ± 0.02 0.07 
EN00647 Pre-Teen Male 2004-04-07 0.03 ± 0.02 0.08 
EN00648 Pre-Teen Female 2004-04-07 0.00 ± 0.00 0.06 
EN00649 Pre-Teen Female 2004-04-07 0.05 ± 0.02 0.08 
EN00649 Pre-Teen Female 2004-06-14 0.17 ± 0.03 0.13 
EN00650 Pre-Teen Female 2004-04-07 0.00 ± 0.00 0.06 
EN00651 Pre-Teen Female 2004-04-07 0.00 ± 0.00 0.06 
EN00652 Pre-Teen Male 2004-04-19 0.05 ± 0.02 0.09 
EN00653 Child Male 2004-04-19 0.00 ± 0.00 0.06 
EN00654 Child Male 2004-04-19 0.00 ± 0.00 0.06 
EN00655 Pre-Teen Male 2004-04-19 0.00 ± 0.00 0.06 
EN00656 Child Male 2004-04-19 0.00 ± 0.00 0.06 
EN00657 Child Female 2004-04-19 0.00 ± 0.00 0.06 
EN00658 Child Female 2004-04-19 0.06 ± 0.02 0.07 
EN00659 Pre-Teen Female 2004-04-19 0.04 ± 0.02 0.11 
EN00660 Pre-Teen Female 2004-04-19 0.00 ± 0.00 0.06 
EN00661 Child Female 2004-04-19 0.00 ± 0.00 0.06 
EN00662 Child Female 2004-04-19 0.00 ± 0.00 0.06 
EN00663 Child Female 2004-04-19 0.00 ± 0.00 0.06 
EN00664 Pre-Teen Female 2004-04-19 0.00 ± 0.00 0.06 
EN00665 Child Male 2004-04-20 0.09 ± 0.04 0.18 
EN00666 Pre-Teen Female 2004-04-20 0.00 ± 0.00 0.06 
EN00667 Pre-Teen Female 2004-04-20 0.00 ± 0.00 0.06 
EN00668 Pre-Teen Female 2004-04-20 0.00 ± 0.00 0.06 
EN00669 Child Female 2004-04-20 0.00 ± 0.00 0.06 
EN00670 Child Female 2004-04-20 0.00 ± 0.00 0.06 
EN00671 Child Male 2004-04-20 0.00 ± 0.00 0.06 
EN00672 Child Female 2004-04-20 0.00 ± 0.00 0.06 
EN00673 Child Male 2004-04-20 0.00 ± 0.00 0.06 
EN00674 Child Female 2004-04-20 0.00 ± 0.00 0.06 
EN00675 Child Male 2004-04-20 0.00 ± 0.00 0.06 
EN00676 Child Female 2004-04-21 0.00 ± 0.00 0.06 
EN00677 Child Male 2004-04-21 0.00 ± 0.00 0.06 
EN00678 Child Female 2004-04-21 0.00 ± 0.00 0.06 
EN00679 Child Male 2004-04-21 0.00 ± 0.00 0.06 
EN00680 Child Female 2004-04-21 0.00 ± 0.00 0.06 
EN00681 Pre-Teen Male 2004-04-21 0.00 ± 0.00 0.06 
EN00682 Adult Male 2004-05-03 0.08 ± 0.03 0.11 
EN00683 Child Male 2004-05-04 0.00 ± 0.00 0.06 
EN00684 Child Male 2004-05-04 0.00 ± 0.00 0.06 
EN00685 Child Male 2004-05-04 0.00 ± 0.00 0.06 
EN00686 Child Male 2004-05-04 0.00 ± 0.00 0.06 
EN00687 Child Male 2004-05-04 0.00 ± 0.00 0.06 
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EN00688 Child Male 2004-05-10 0.00 ± 0.00 0.06 
EN00689 Child Male 2004-05-10 0.00 ± 0.00 0.06 
EN00689 Child Male 2004-07-08 0.31 ± 0.04 0.17 
EN00690 Child Male 2004-05-10 0.00 ± 0.00 0.06 
EN00691 Child Male 2004-05-10 0.00 ± 0.00 0.06 
EN00692 Child Male 2004-05-10 0.00 ± 0.00 0.06 
EN00693 Adult Female 2004-05-10 0.00 ± 0.00 0.06 
EN00694 Child Female 2004-05-12 0.00 ± 0.00 0.06 
EN00695 Child Female 2004-05-12 0.00 ± 0.00 0.06 
EN00696 Child Female 2004-05-12 0.00 ± 0.00 0.06 
EN00697 Child Female 2004-05-12 0.00 ± 0.00 0.06 
EN00698 Child Female 2004-05-12 0.00 ± 0.00 0.06 
EN00699 Child Male 2004-05-13 0.00 ± 0.00 0.06 
EN00700 Child Male 2004-05-13 0.00 ± 0.00 0.06 
EN00701 Child Male 2004-05-13 0.00 ± 0.00 0.06 
EN00702 Child Female 2004-05-13 0.00 ± 0.00 0.06 
EN00703 Child Female 2004-05-14 0.00 ± 0.00 0.06 
EN00704 Child Female 2004-05-14 0.00 ± 0.00 0.06 
EN00705 Child Male 2004-05-17 0.00 ± 0.00 0.06 
EN00706 Child Male 2004-05-17 0.00 ± 0.00 0.06 
EN00708 Adult Male 2004-05-21 0.40 ± 0.05 0.20 
EN00709 Adult Female 2004-05-22 0.24 ± 0.04 0.19 
EN00710 Adult Male 2004-05-25 0.33 ± 0.04 0.16 
EN00710 Adult Male 2004-07-08 0.37 ± 0.04 0.19 
EN00711 Adult Female 2004-05-25 0.14 ± 0.03 0.12 
EN00712 Adult Male 2004-05-25 0.07 ± 0.02 0.10 
EN00713 Adult Male 2004-05-25 0.00 ± 0.00 0.06 
EN00713 Adult Male 2004-05-25 0.08 ± 0.02 0.10 
EN00714 Adult Male 2004-05-27 0.06 ± 0.02 0.08 
EN00715 Adult Male 2004-06-01 0.00 ± 0.00 0.06 
EN00716 Adult Male 2004-06-01 0.00 ± 0.00 0.06 
EN00717 Child Male 2004-06-07 0.58 ± 0.04 0.17 
EN00718 Child Male 2004-06-07 0.47 ± 0.04 0.18 
EN00719 Adult Female 2004-06-08 0.05 ± 0.02 0.08 
EN00720 Adult Male 2004-06-09 0.29 ± 0.05 0.23 
EN00721 Adult Female 2004-06-09 0.18 ± 0.03 0.13 
EN00722 Adult Male 2004-06-09 0.33 ± 0.04 0.16 
EN00723 Teenager Female 2004-06-14 0.26 ± 0.04 0.17 
EN00724 Adult Female 2004-06-14 0.13 ± 0.03 0.14 
EN00725 Adult Female 2004-06-16 0.15 ± 0.02 0.12 
EN00726 Adult Female 2004-06-16 0.12 ± 0.04 0.17 
EN00728 Teenager Male 2004-07-05 0.07 ± 0.02 0.09 
EN00729 Adult Male 2004-07-05 0.00 ± 0.00 0.06 
EN00730 Teenager Male 2004-07-12 0.29 ± 0.04 0.17 
EN00731 Adult Female 2004-07-19 0.00 ± 0.00 0.06 
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EN00732 Adult Female 2004-07-19 0.07 ± 0.02 0.10 
EN00733 Adult Male 2004-07-21 0.31 ± 0.03 0.15 
EN00734 Adult Male 2004-07-21 0.53 ± 0.04 0.18 
EN00735 Adult Male 2004-07-22 0.00 ± 0.00 0.06 
EN00736 Adult Female 2004-07-28 0.00 ± 0.00 0.06 
EN00737 Adult Female 2004-07-30 0.11 ± 0.02 0.10 
EN00738 Adult Male 2004-08-02 0.12 ± 0.02 0.11 
EN00739 Adult Male 2004-08-02 0.05 ± 0.02 0.08 
EN00740 Adult Male 2004-08-05 0.44 ± 0.05 0.20 
EN00741 Teenager Male 2004-09-29 0.33 ± 0.04 0.16 
EN00742 Adult Male 2004-10-01 0.00 ± 0.00 0.06 
EN00743 Adult Male 2004-12-07 0.04 ± 0.02 0.11 
EN00744 Child Male 2004-12-09 0.00 ± 0.00 0.06 
EN00745 Adult Male 2004-12-09 0.00 ± 0.00 0.06 
EN00746 Adult Male 2004-12-15 0.27 ± 0.04 0.18 
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EN00002 Adult Male 2002-04-15 1.83 ± 0.60 0.70 0.73 ± 0.87 2.62 
EN00002 Adult Male 2002-04-19 0.66 ± 0.38 0.70 0.52 ± 0.72 2.62 
EN00003 Adult Male 2002-04-12 0.32 ± 0.29 0.70 -0.02 ± 0.59 2.62 
EN00009 Adult Male 2002-04-17 0.28 ± 0.40 0.70 -0.02 ± 1.22 2.62 
EN00011 Adult Male 2003-08-12 0.26 ± 0.20 0.16 -0.13 ± 0.47 1.42 
EN00012 Adult Male 2002-04-18 0.21 ± 0.27 0.70 -0.02 ± 0.60 2.62 
EN00013 Adult Male 2002-04-17 0.57 ± 0.49 0.70 -0.02 ± 1.27 2.62 
EN00014 Adult Male 2003-08-11 0.18 ± 0.19 0.16 0.79 ± 0.69 1.42 
EN00019 Adult Male 2003-08-07 0.20 ± 0.38 0.66 -0.13 ± 1.38 1.77 
EN00021 Adult Male 2003-11-27 0.18 ± 0.26 0.49 1.65 ± 1.29 2.61 
EN00024 Adult Male 2002-04-15 0.12 ± 0.26 0.70 -0.02 ± 0.87 2.62 
EN00024 Adult Male 2002-04-19 0.50 ± 0.34 0.70 -0.02 ± 0.60 2.62 
EN00024 Adult Male 2003-08-07 0.62 ± 0.41 0.66 -0.13 ± 0.78 1.77 
EN00027 Adult Male 2002-04-18 0.42 ± 0.34 0.70 -0.02 ± 0.70 2.62 
EN00028 Adult Male 2002-04-18 0.13 ± 0.27 0.70 0.76 ± 1.39 2.62 
EN00029 Adult Male 2002-04-18 -0.07 ± 0.31 0.70 -0.02 ± 0.99 2.62 
EN00029 Adult Male 2003-08-11 -0.07 ± 0.13 0.16 -0.13 ± 0.49 1.42 
EN00030 Adult Male 2002-04-12 0.28 ± 0.31 0.70 -0.02 ± 0.70 2.62 
EN00032 Adult Male 2003-08-07 0.49 ± 0.35 0.66 -0.13 ± 0.69 1.77 
EN00033 Adult Male 2002-04-17 -0.07 ± 0.29 0.70 -0.02 ± 0.70 2.62 
EN00036 Adult Male 2003-08-13 0.07 ± 0.15 0.16 -0.13 ± 0.58 1.42 
EN00037 Adult Male 2002-04-15 0.16 ± 0.30 0.70 -0.02 ± 0.77 2.62 
EN00038 Adult Male 2002-04-17 0.14 ± 0.28 0.70 0.78 ± 1.42 2.62 
EN00038 Adult Male 2003-08-07 -0.04 ± 0.17 0.66 0.82 ± 0.74 1.77 
EN00039 Adult Male 2002-04-17 0.21 ± 0.27 0.70 -0.02 ± 0.62 2.62 
EN00042 Adult Male 2003-08-12 0.10 ± 0.19 0.16 -0.13 ± 0.71 1.42 
EN00044 Adult Male 2003-08-08 0.51 ± 0.36 0.66 -0.13 ± 0.72 1.77 
EN00057 Adult Male 2003-11-27 -0.05 ± 0.22 0.49 0.59 ± 0.78 2.61 
EN00057 Adult Male 2003-11-29 0.92 ± 0.50 0.49 2.51 ± 1.55 2.61 
EN00059 Adult Male 2003-08-08 -0.17 ± 0.25 0.66 -0.13 ± 0.91 1.77 
EN00064 Adult Male 2003-11-28 -0.05 ± 0.38 0.49 1.21 ± 1.35 2.61 
EN00070 Adult Male 2002-04-12 0.12 ± 0.26 0.70 -0.02 ± 0.83 2.62 
EN00084 Adult Male 2003-08-12 0.50 ± 0.30 0.16 0.40 ± 0.58 1.42 
EN00086 Adult Male 2002-04-15 0.10 ± 0.25 0.70 -0.02 ± 0.68 2.62 
EN00092 Adult Male 2002-04-15 0.72 ± 0.43 0.70 -0.02 ± 0.94 2.62 
EN00100 Adult Male 2002-04-12 0.37 ± 0.36 0.70 -0.02 ± 0.93 2.62 
EN00102 Adult Male 2003-08-09 0.16 ± 0.25 0.16 -0.13 ± 0.91 1.42 
EN00102 Adult Male 2003-08-13 0.59 ± 0.34 0.16 -0.13 ± 0.65 1.42 
EN00104 Adult Male 2003-08-09 0.77 ± 0.43 0.16 2.29 ± 1.42 1.42 
EN00104 Adult Male 2003-08-13 0.14 ± 0.22 0.16 -0.13 ± 0.80 1.42 
EN00107 Adult Male 2002-04-15 -0.07 ± 0.33 0.70 -0.02 ± 1.17 2.62 
EN00108 Adult Male 2003-08-07 0.89 ± 0.54 0.66 -0.13 ± 1.05 1.77 
EN00108 Adult Male 2003-08-09 0.32 ± 0.24 0.16 -0.13 ± 0.54 1.42 
EN00110 Adult Male 2003-08-13 -0.07 ± 0.15 0.16 0.86 ± 0.74 1.42 
EN00111 Adult Male 2003-11-27 -0.80 ± 0.51 0.49 -0.08 ± 1.12 2.61 
EN00114 Adult Male 2002-04-19 0.23 ± 0.28 0.70 -0.02 ± 0.69 2.62 
EN00116 Adult Male 2003-08-09 -0.07 ± 0.17 0.16 -0.13 ± 0.63 1.42 
EN00122 Adult Male 2003-08-11 0.05 ± 0.14 0.16 -0.13 ± 0.51 1.42 
EN00124 Adult Male 2003-08-11 0.17 ± 0.18 0.16 -0.13 ± 0.51 1.42 
EN00125 Adult Male 2002-04-19 0.28 ± 0.31 0.70 0.61 ± 0.95 2.62 
EN00125 Adult Male 2003-08-07 0.80 ± 0.40 0.66 -0.13 ± 0.64 1.77 
EN00139 Adult Male 2003-08-12 0.05 ± 0.14 0.16 0.33 ± 0.51 1.42 
EN00141 Adult Male 2002-04-19 0.13 ± 0.27 0.70 -0.02 ± 0.75 2.62 
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EN00145 Adult Male 2002-04-12 0.69 ± 0.48 0.70 -0.02 ± 1.00 2.62 
EN00147 Adult Male 2003-08-12 -0.07 ± 0.13 0.16 -0.13 ± 0.48 1.42 
EN00151 Adult Male 2003-08-08 0.53 ± 0.51 0.66 6.65 ± 3.05 1.77 
EN00160 Adult Male 2002-04-17 0.66 ± 0.46 0.70 0.85 ± 1.17 2.62 
EN00160 Adult Male 2002-04-18 0.35 ± 0.35 0.70 2.18 ± 2.57  2.62 
EN00161 Teenager Male 2002-04-19 0.33 ± 0.34 0.70 -0.02 ± 0.73 2.62 
EN00174 Adult Male 2003-08-09 0.42 ± 0.29 0.16 1.14 ± 0.93 1.42 
EN00182 Teenager Male 2003-11-29 -0.05 ± 0.41 0.49 -0.08 ± 1.32 2.61 
EN00184 Adult Male 2003-08-08 0.14 ± 0.22 0.16 0.67 ± 0.83 1.42 
EN00189 Adult Male 2003-08-13 -0.07 ± 0.19 0.16 -0.13 ± 0.70 1.42 
EN00197 Adult Female 2002-04-08 0.04 ± 0.22 0.70 0.38 ± 0.77 2.62 
EN00198 Adult Female 2002-04-08 0.23 ± 0.35 0.70 -0.02 ± 1.02 2.62 
EN00201 Adult Female 2003-08-05 0.51 ± 0.41 0.66 -0.13 ± 0.91 1.77 
EN00204 Adult Female 2002-04-10 0.09 ± 0.24 0.70 0.49 ± 0.94 2.62 
EN00204 Adult Female 2003-08-05 -0.17 ± 0.31 0.66 -0.13 ± 1.07 1.77 
EN00207 Adult Female 2003-11-25 0.23 ± 0.31 0.49 -0.08 ± 1.14 2.61 
EN00221 Adult Female 2002-04-09 0.08 ± 0.24 0.70 -0.02 ± 0.67 2.62 
EN00242 Adult Female 2002-04-08 -0.07 ± 0.22 0.70 -0.02 ± 0.49 2.62 
EN00244 Adult Male 2003-08-11 0.17 ± 0.18 0.16 -0.13 ± 0.51 1.42 
EN00246 Adult Female 2003-08-04 -0.17 ± 0.17 0.66 -0.13 ± 0.59 1.77 
EN00246 Adult Female 2003-08-06 0.00 ± 0.20 0.66 -0.13 ± 0.73 1.77 
EN00251 Adult Female 2002-04-09 0.36 ± 0.31 0.70 -0.02 ± 0.68 2.62 
EN00251 Adult Female 2003-08-05 0.01 ± 0.17 0.66 0.93 ± 0.69 1.77 
EN00252 Adult Female 2002-04-11 0.17 ± 0.30 0.70 -0.02 ± 0.91 2.62 
EN00262 Adult Female 2003-11-25 -0.05 ± 0.37 0.49 2.30 ± 1.73 2.61 
EN00264 Adult Female 2002-04-10 -0.07 ± 0.23 0.70 -0.02 ± 0.56 2.62 
EN00267 Adult Female 2003-08-06 0.00 ± 0.21 0.66 -0.13 ± 0.73 1.77 
EN00268 Adult Female 2002-04-09 -0.07 ± 0.23 0.70 -0.02 ± 0.61 2.62 
EN00269 Adult Female 2002-04-09 0.64 ± 0.45 0.70 -0.02 ± 0.81 2.62 
EN00272 Teenager Female 2003-08-04 -0.17 ± 0.22 0.66 -0.13 ± 0.83 1.77 
EN00272 Teenager Female 2003-08-06 -0.17 ± 0.16 0.66 -0.13 ± 0.54 1.77 
EN00273 Adult Female 2002-04-10 0.20 ± 0.32 0.70 -0.02 ± 1.01 2.62 
EN00278 Adult Female 2003-08-05 0.35 ± 0.28 0.70 -0.13 ± 0.59 1.77 
EN00288 Adult Female 2002-04-08 -0.07 ± 0.22 0.70 -0.02 ± 0.48 2.62 
EN00290 Adult Female 2002-04-08 0.44 ± 0.32 0.70 0.45 ± 0.66 2.62 
EN00290 Adult Female 2002-04-11 -0.07 ± 0.23 0.70 -0.02 ± 0.73 2.62 
EN00291 Adult Female 2002-04-09 0.20 ± 0.27 0.70 -0.02 ± 0.59 2.62 
EN00293 Adult Female 2002-04-11 -0.07 ± 0.30 0.70 -0.02 ± 0.93 2.62 
EN00294 Adult Female 2002-04-10 0.21 ± 0.27 0.70 -0.02 ± 0.64 2.62 
EN00296 Adult Female 2002-04-10 -0.07 ± 0.22 0.70 -0.02 ± 0.52  2.62 
EN00304 Teenager Female 2002-04-08 0.17 ± 0.25 0.70 0.47 ± 0.76 2.62 
EN00304 Teenager Female 2002-04-11 0.10 ± 0.25 0.70 1.29 ± 2.09 2.62 
EN00329 Adult Female 2003-08-05 0.31 ± 0.24 0.66 0.24 ± 0.48 1.77 
EN00334 Adult Female 2003-08-06 0.10 ± 0.22  0.66 -0.13 ± 0.60 1.77 
EN00337 Adult Female 2003-11-24 -0.05 ± 0.32 0.49 -0.08 ± 1.15 2.61 
EN00339 Adult Female 2003-08-05 0.36 ± 0.33 0.66 -0.13 ± 0.71 1.77 
EN00346 Adult Female 2002-04-09 0.26 ± 0.27 0.70 -0.02 ± 0.55 2.62 
EN00359 Adult Male 2003-08-12 0.06 ± 0.15 0.16 -0.13 ± 0.61 1.42 
EN00364 Adult Male 2003-08-11 0.65 ± 0.30 0.16 -0.13 ± 0.49 1.42 
EN00375 Adult Male 2002-04-18 0.61 ± 0.43 0.70 -0.02 ± 0.81 2.62 
EN00376 Adult Male 2003-08-13 -0.07 ± 0.11 0.16 -0.13 ± 0.42 1.42 
EN00382 Adult Male 2003-11-28 0.62 ± 0.40 0.49 0.69 ± 0.87 2.61 
EN00383 Adult Male 2003-11-28 0.11 ± 0.20 0.49 1.66 ± 1.08 2.61 
EN00391 Adult Male 2003-08-08 -0.17 ± 0.16 0.66 -0.13 ± 0.53 1.77 
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EN00400 Adult Female 2003-11-25 0.26 ± 0.25 0.49 0.46 ± 0.68 2.61 
EN00403 Adult Male 2003-08-09 0.04 ± 0.13 0.16 -0.13 ± 0.48 1.42 
EN00407 Adult Female 2002-04-10 0.30 ± 0.28 0.70 -0.02 ± 0.55 2.62 
EN00421 Adult Female 2003-08-06 -0.17 ± 0.27 0.66 0.90 ± 1.07 1.77 
EN00422 Adult Male 2003-11-27 7.76 ± 1.18 0.49 -0.08 ± 0.76 2.61 
EN00430 Adult Female 2003-11-24 0.32 ± 0.29 0.49 -0.08 ± 0.78 2.61 
EN00430 Adult Female 2003-11-25 0.59 ± 0.39 0.49 0.70 ± 0.88 2.61 
EN00431 Adult Female 2003-08-06 0.45 ± 0.33 0.66 -0.13 ± 0.64 1.77 
EN00461 Adult Female 2003-08-04 0.11 ± 0.30 0.66 -0.13 ± 1.11 1.77 
EN00463 Teenager Male 2003-11-29 0.17 ± 0.25 0.49 -0.08 ± 0.92 2.61 
EN00467 Adult Male 2003-08-08 0.71 ± 0.36 0.16 -0.13 ± 0.64 1.42 
EN00474 Teenager Female 2003-08-04 0.31 ± 0.30 0.66 -0.13 ± 0.69 1.77 
EN00509 Teenager Female 2003-11-24 -0.05 ± 0.37 0.49 1.26 ± 1.40 2.61 
EN00511 Teenager Male 2003-11-29 0.32 ± 0.39 0.49 -0.08 ± 1.37 2.61 
EN00512 Teenager Male 2003-11-29 -0.05 ± 0.25 0.49 -0.08 ± 0.87 2.61 
EN00519 Teenager Male 2003-11-29 0.28 ± 0.26 0.49 -0.08 ± 0.72 2.61 
EN00539 Adult Female 2003-11-25 -0.05 ± 0.25 0.49 0.70 ± 0.88 2.61 
 
